,title,geo_accession,status,submission_date,last_update_date,type,channel_count,source_name_ch1,organism_ch1,characteristics_ch1,characteristics_ch1.1,characteristics_ch1.2,characteristics_ch1.3,characteristics_ch1.4,characteristics_ch1.5,characteristics_ch1.6,characteristics_ch1.7,characteristics_ch1.8,characteristics_ch1.9,characteristics_ch1.10,characteristics_ch1.11,characteristics_ch1.12,characteristics_ch1.13,characteristics_ch1.14,characteristics_ch1.15,characteristics_ch1.16,characteristics_ch1.17,characteristics_ch1.18,characteristics_ch1.19,characteristics_ch1.20,characteristics_ch1.21,molecule_ch1,extract_protocol_ch1,label_ch1,label_protocol_ch1,taxid_ch1,source_name_ch2,organism_ch2,characteristics_ch2,molecule_ch2,extract_protocol_ch2,label_ch2,label_protocol_ch2,taxid_ch2,hyb_protocol,scan_protocol,scan_protocol.1,description,data_processing,platform_id,contact_name,contact_institute,contact_address,contact_city,contact_state,contact_zip/postal_code,contact_country,supplementary_file,data_row_count,Age:ch1,Annotation:ch1,BAC features:ch1,EGFR status:ch1,Evidence of relapse:ch1,Expression profile-based classification:ch1,Gefitinib treatment:ch1,Grade:ch1,Histology:ch1,Invasion:ch1,K-ras Status:ch1,Necrosis:ch1,p53 Status:ch1,Position in Figure 1 (L to R):ch1,Position in Figure 2 (L to R):ch1,pStage:ch1,pTNM:ch1,Sex:ch1,Site of relapse:ch1,Smoking (BI):ch1,Status:ch1,Survival (days):ch1
GSM302996,Patient 001 with adenocarcinoma,GSM302996,Public on Apr 01 2009,Jul 02 2008,Jul 02 2008,RNA,2,Primary lung tumor,Homo sapiens,Annotation: AD001,Position in Figure 1 (L to R): 90,Age: 71,Sex: M,Histology: AD,Smoking (BI): 1020,pTNM: T2N0M0,pStage: IB,Status: Dead,Survival (days): 1326,Evidence of relapse: Y,Site of relapse: PM,EGFR status: Mut,K-ras Status: Wt,p53 Status: Wt,Gefitinib treatment:,Position in Figure 2 (L to R): 68,Expression profile-based classification: TRU-a,Invasion: Definite,Necrosis: Negative,Grade: Poorly,BAC features: -,total RNA,"Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 250 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.",Cy5,"cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescent Linear Amplification kit (Agilent Technologies, Palo Alto, CA).",9606,"Total RNA from 20 lung cell lines representing all major histological types of lung cancers, labeled with Cyanine-3 (green).",Homo sapiens,n/a,total RNA,"Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 250 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.",Cy3,"cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescent Linear Amplification kit (Agilent Technologies, Palo Alto, CA).",9606,"Cy5-sample cRNA and Cy3-common reference cRNA were hybridized to a custom Agilent oligonucleotide microarray, containing a total of 21,619 spots corresponding to 18,175 unique genes, followed by confocal laser scanning (Agilent Technologies).",Scanned on an Agilent G2565AA scanner.,Images were quantified using Agilent Feature Extraction Software (version A.7.5).,n/a,"LOWESS normalized, background subtracted VALUE data obtained from log10 of processed Red signal/processed Green signal. Agilent software was used.",GPL7015,"Takashi,,Takahashi",Aichi Cancer Center,"1-1 Kanokoden, Chikusa-ku",Nagoya,Aichi,464-8681,Japan,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM302nnn/GSM302996/suppl/GSM302996.txt.gz,21619,71,AD001,-,Mut,Y,TRU-a,,Poorly,AD,Definite,Wt,Negative,Wt,90,68,IB,T2N0M0,M,PM,1020,Dead,1326
GSM302997,Patient 002 with adenocarcinoma,GSM302997,Public on Apr 01 2009,Jul 02 2008,Jul 02 2008,RNA,2,Primary lung tumor,Homo sapiens,Annotation: AD002,Position in Figure 1 (L to R): 71,Age: 49,Sex: F,Histology: AD,Smoking (BI): 0,pTNM: T1N0M0,pStage: IA,Status: Alive,Survival (days): 3275,Evidence of relapse: N,Site of relapse:,EGFR status: Wt,K-ras Status: Wt,p53 Status: Wt,Gefitinib treatment:,Position in Figure 2 (L to R): 54,Expression profile-based classification: TRU-a,Invasion: Definite,Necrosis: Negative,Grade: Moderately,BAC features: -,total RNA,"Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 250 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.",Cy5,"cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescent Linear Amplification kit (Agilent Technologies, Palo Alto, CA).",9606,"Total RNA from 20 lung cell lines representing all major histological types of lung cancers, labeled with Cyanine-3 (green).",Homo sapiens,n/a,total RNA,"Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 250 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.",Cy3,"cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescent Linear Amplification kit (Agilent Technologies, Palo Alto, CA).",9606,"Cy5-sample cRNA and Cy3-common reference cRNA were hybridized to a custom Agilent oligonucleotide microarray, containing a total of 21,619 spots corresponding to 18,175 unique genes, followed by confocal laser scanning (Agilent Technologies).",Scanned on an Agilent G2565AA scanner.,Images were quantified using Agilent Feature Extraction Software (version A.7.5).,n/a,"LOWESS normalized, background subtracted VALUE data obtained from log10 of processed Red signal/processed Green signal. Agilent software was used.",GPL7015,"Takashi,,Takahashi",Aichi Cancer Center,"1-1 Kanokoden, Chikusa-ku",Nagoya,Aichi,464-8681,Japan,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM302nnn/GSM302997/suppl/GSM302997.txt.gz,21619,49,AD002,-,Wt,N,TRU-a,,Moderately,AD,Definite,Wt,Negative,Wt,71,54,IA,T1N0M0,F,,0,Alive,3275
GSM302998,Patient 003 with adenocarcinoma,GSM302998,Public on Apr 01 2009,Jul 02 2008,Jul 02 2008,RNA,2,Primary lung tumor,Homo sapiens,Annotation: AD003,Position in Figure 1 (L to R): 96,Age: 51,Sex: F,Histology: AD,Smoking (BI): 0,pTNM: T2N2M0,pStage: IIIA,Status: Dead,Survival (days): 1687,Evidence of relapse: Y,Site of relapse: PM,EGFR status: Wt,K-ras Status: Wt,p53 Status: Mut,Gefitinib treatment:,Position in Figure 2 (L to R): 65,Expression profile-based classification: TRU-a,Invasion: Definite,Necrosis: Negative,Grade: Moderately,BAC features: -,total RNA,"Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 250 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.",Cy5,"cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescent Linear Amplification kit (Agilent Technologies, Palo Alto, CA).",9606,"Total RNA from 20 lung cell lines representing all major histological types of lung cancers, labeled with Cyanine-3 (green).",Homo sapiens,n/a,total RNA,"Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 250 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.",Cy3,"cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescent Linear Amplification kit (Agilent Technologies, Palo Alto, CA).",9606,"Cy5-sample cRNA and Cy3-common reference cRNA were hybridized to a custom Agilent oligonucleotide microarray, containing a total of 21,619 spots corresponding to 18,175 unique genes, followed by confocal laser scanning (Agilent Technologies).",Scanned on an Agilent G2565AA scanner.,Images were quantified using Agilent Feature Extraction Software (version A.7.5).,n/a,"LOWESS normalized, background subtracted VALUE data obtained from log10 of processed Red signal/processed Green signal. Agilent software was used.",GPL7015,"Takashi,,Takahashi",Aichi Cancer Center,"1-1 Kanokoden, Chikusa-ku",Nagoya,Aichi,464-8681,Japan,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM302nnn/GSM302998/suppl/GSM302998.txt.gz,21619,51,AD003,-,Wt,Y,TRU-a,,Moderately,AD,Definite,Wt,Negative,Mut,96,65,IIIA,T2N2M0,F,PM,0,Dead,1687
GSM302999,Patient 004 with adenocarcinoma,GSM302999,Public on Apr 01 2009,Jul 02 2008,Jul 02 2008,RNA,2,Primary lung tumor,Homo sapiens,Annotation: AD004,Position in Figure 1 (L to R): 119,Age: 51,Sex: F,Histology: AD,Smoking (BI): 0,pTNM: T1N1M0,pStage: IIA,Status: Alive,Survival (days): 3214,Evidence of relapse: N,Site of relapse:,EGFR status: Wt,K-ras Status: Wt,p53 Status: Wt,Gefitinib treatment:,Position in Figure 2 (L to R): 90,Expression profile-based classification: TRU-b,Invasion: Definite,Necrosis: Negative,Grade: Moderately,BAC features: +,total RNA,"Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 250 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.",Cy5,"cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescent Linear Amplification kit (Agilent Technologies, Palo Alto, CA).",9606,"Total RNA from 20 lung cell lines representing all major histological types of lung cancers, labeled with Cyanine-3 (green).",Homo sapiens,n/a,total RNA,"Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 250 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.",Cy3,"cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescent Linear Amplification kit (Agilent Technologies, Palo Alto, CA).",9606,"Cy5-sample cRNA and Cy3-common reference cRNA were hybridized to a custom Agilent oligonucleotide microarray, containing a total of 21,619 spots corresponding to 18,175 unique genes, followed by confocal laser scanning (Agilent Technologies).",Scanned on an Agilent G2565AA scanner.,Images were quantified using Agilent Feature Extraction Software (version A.7.5).,n/a,"LOWESS normalized, background subtracted VALUE data obtained from log10 of processed Red signal/processed Green signal. Agilent software was used.",GPL7015,"Takashi,,Takahashi",Aichi Cancer Center,"1-1 Kanokoden, Chikusa-ku",Nagoya,Aichi,464-8681,Japan,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM302nnn/GSM302999/suppl/GSM302999.txt.gz,21619,51,AD004,+,Wt,N,TRU-b,,Moderately,AD,Definite,Wt,Negative,Wt,119,90,IIA,T1N1M0,F,,0,Alive,3214
GSM303000,Patient 005 with adenocarcinoma,GSM303000,Public on Apr 01 2009,Jul 02 2008,Jul 02 2008,RNA,2,Primary lung tumor,Homo sapiens,Annotation: AD005,Position in Figure 1 (L to R): 56,Age: 67,Sex: F,Histology: AD,Smoking (BI): 0,pTNM: T1N2M0,pStage: IIIA,Status: Dead,Survival (days): 1200,Evidence of relapse: Y,Site of relapse: PM,EGFR status: Mut,K-ras Status: Wt,p53 Status: Mut,Gefitinib treatment:,Position in Figure 2 (L to R): 64,Expression profile-based classification: TRU-a,Invasion: Definite,Necrosis: Negative,Grade: Well,BAC features: +,total RNA,"Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 250 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.",Cy5,"cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescent Linear Amplification kit (Agilent Technologies, Palo Alto, CA).",9606,"Total RNA from 20 lung cell lines representing all major histological types of lung cancers, labeled with Cyanine-3 (green).",Homo sapiens,n/a,total RNA,"Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 250 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.",Cy3,"cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescent Linear Amplification kit (Agilent Technologies, Palo Alto, CA).",9606,"Cy5-sample cRNA and Cy3-common reference cRNA were hybridized to a custom Agilent oligonucleotide microarray, containing a total of 21,619 spots corresponding to 18,175 unique genes, followed by confocal laser scanning (Agilent Technologies).",Scanned on an Agilent G2565AA scanner.,Images were quantified using Agilent Feature Extraction Software (version A.7.5).,n/a,"LOWESS normalized, background subtracted VALUE data obtained from log10 of processed Red signal/processed Green signal. Agilent software was used.",GPL7015,"Takashi,,Takahashi",Aichi Cancer Center,"1-1 Kanokoden, Chikusa-ku",Nagoya,Aichi,464-8681,Japan,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM303nnn/GSM303000/suppl/GSM303000.txt.gz,21619,67,AD005,+,Mut,Y,TRU-a,,Well,AD,Definite,Wt,Negative,Mut,56,64,IIIA,T1N2M0,F,PM,0,Dead,1200
GSM303001,Patient 006 with adenocarcinoma,GSM303001,Public on Apr 01 2009,Jul 02 2008,Jul 02 2008,RNA,2,Primary lung tumor,Homo sapiens,Annotation: AD006,Position in Figure 1 (L to R): 95,Age: 66,Sex: M,Histology: AD,Smoking (BI): 100,pTNM: T3N1M0,pStage: IIIA,Status: Dead,Survival (days): 223,Evidence of relapse: Y,Site of relapse: Brain,EGFR status: Mut,K-ras Status: Wt,p53 Status: Wt,Gefitinib treatment:,Position in Figure 2 (L to R): 69,Expression profile-based classification: TRU-a,Invasion: Definite,Necrosis: Positive,Grade: Moderately,BAC features: -,total RNA,"Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 250 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.",Cy5,"cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescent Linear Amplification kit (Agilent Technologies, Palo Alto, CA).",9606,"Total RNA from 20 lung cell lines representing all major histological types of lung cancers, labeled with Cyanine-3 (green).",Homo sapiens,n/a,total RNA,"Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 250 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.",Cy3,"cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescent Linear Amplification kit (Agilent Technologies, Palo Alto, CA).",9606,"Cy5-sample cRNA and Cy3-common reference cRNA were hybridized to a custom Agilent oligonucleotide microarray, containing a total of 21,619 spots corresponding to 18,175 unique genes, followed by confocal laser scanning (Agilent Technologies).",Scanned on an Agilent G2565AA scanner.,Images were quantified using Agilent Feature Extraction Software (version A.7.5).,n/a,"LOWESS normalized, background subtracted VALUE data obtained from log10 of processed Red signal/processed Green signal. Agilent software was used.",GPL7015,"Takashi,,Takahashi",Aichi Cancer Center,"1-1 Kanokoden, Chikusa-ku",Nagoya,Aichi,464-8681,Japan,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM303nnn/GSM303001/suppl/GSM303001.txt.gz,21619,66,AD006,-,Mut,Y,TRU-a,,Moderately,AD,Definite,Wt,Positive,Wt,95,69,IIIA,T3N1M0,M,Brain,100,Dead,223
GSM303002,Patient 007 with adenocarcinoma,GSM303002,Public on Apr 01 2009,Jul 02 2008,Jul 02 2008,RNA,2,Primary lung tumor,Homo sapiens,Annotation: AD007,Position in Figure 1 (L to R): 73,Age: 71,Sex: F,Histology: AD,Smoking (BI): 0,pTNM: T1N0M0,pStage: IA,Status: Alive,Survival (days): 3245,Evidence of relapse: N,Site of relapse:,EGFR status: Mut,K-ras Status: Wt,p53 Status: Wt,Gefitinib treatment:,Position in Figure 2 (L to R): 53,Expression profile-based classification: TRU-a,Invasion: Definite but focal,Necrosis: Negative,Grade: Moderately,BAC features: -,total RNA,"Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 250 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.",Cy5,"cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescent Linear Amplification kit (Agilent Technologies, Palo Alto, CA).",9606,"Total RNA from 20 lung cell lines representing all major histological types of lung cancers, labeled with Cyanine-3 (green).",Homo sapiens,n/a,total RNA,"Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 250 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.",Cy3,"cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescent Linear Amplification kit (Agilent Technologies, Palo Alto, CA).",9606,"Cy5-sample cRNA and Cy3-common reference cRNA were hybridized to a custom Agilent oligonucleotide microarray, containing a total of 21,619 spots corresponding to 18,175 unique genes, followed by confocal laser scanning (Agilent Technologies).",Scanned on an Agilent G2565AA scanner.,Images were quantified using Agilent Feature Extraction Software (version A.7.5).,n/a,"LOWESS normalized, background subtracted VALUE data obtained from log10 of processed Red signal/processed Green signal. Agilent software was used.",GPL7015,"Takashi,,Takahashi",Aichi Cancer Center,"1-1 Kanokoden, Chikusa-ku",Nagoya,Aichi,464-8681,Japan,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM303nnn/GSM303002/suppl/GSM303002.txt.gz,21619,71,AD007,-,Mut,N,TRU-a,,Moderately,AD,Definite but focal,Wt,Negative,Wt,73,53,IA,T1N0M0,F,,0,Alive,3245
GSM303003,Patient 008 with adenocarcinoma,GSM303003,Public on Apr 01 2009,Jul 02 2008,Jul 02 2008,RNA,2,Primary lung tumor,Homo sapiens,Annotation: AD008,Position in Figure 1 (L to R): 75,Age: 62,Sex: F,Histology: AD,Smoking (BI): 0,pTNM: T4N0M0,pStage: IIIB,Status: Alive,Survival (days): 3274,Evidence of relapse: N,Site of relapse:,EGFR status: Wt,K-ras Status: Mut,p53 Status: Wt,Gefitinib treatment:,Position in Figure 2 (L to R): 56,Expression profile-based classification: TRU-a,Invasion: Definite but focal,Necrosis: Negative,Grade: Well,BAC features: -,total RNA,"Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 250 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.",Cy5,"cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescent Linear Amplification kit (Agilent Technologies, Palo Alto, CA).",9606,"Total RNA from 20 lung cell lines representing all major histological types of lung cancers, labeled with Cyanine-3 (green).",Homo sapiens,n/a,total RNA,"Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 250 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.",Cy3,"cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescent Linear Amplification kit (Agilent Technologies, Palo Alto, CA).",9606,"Cy5-sample cRNA and Cy3-common reference cRNA were hybridized to a custom Agilent oligonucleotide microarray, containing a total of 21,619 spots corresponding to 18,175 unique genes, followed by confocal laser scanning (Agilent Technologies).",Scanned on an Agilent G2565AA scanner.,Images were quantified using Agilent Feature Extraction Software (version A.7.5).,n/a,"LOWESS normalized, background subtracted VALUE data obtained from log10 of processed Red signal/processed Green signal. Agilent software was used.",GPL7015,"Takashi,,Takahashi",Aichi Cancer Center,"1-1 Kanokoden, Chikusa-ku",Nagoya,Aichi,464-8681,Japan,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM303nnn/GSM303003/suppl/GSM303003.txt.gz,21619,62,AD008,-,Wt,N,TRU-a,,Well,AD,Definite but focal,Mut,Negative,Wt,75,56,IIIB,T4N0M0,F,,0,Alive,3274
GSM303004,Patient 009 with adenocarcinoma,GSM303004,Public on Apr 01 2009,Jul 02 2008,Jul 02 2008,RNA,2,Primary lung tumor,Homo sapiens,Annotation: AD009,Position in Figure 1 (L to R): 85,Age: 47,Sex: F,Histology: AD,Smoking (BI): 120,pTNM: T2N2M0,pStage: IIIA,Status: Dead,Survival (days): 511,Evidence of relapse: Y,"Site of relapse: Liver, adrenal",EGFR status: Mut,K-ras Status: Wt,p53 Status: Wt,Gefitinib treatment:,Position in Figure 2 (L to R): 59,Expression profile-based classification: TRU-a,Invasion: Definite,Necrosis: Positive,Grade: Poorly,BAC features: -,total RNA,"Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 250 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.",Cy5,"cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescent Linear Amplification kit (Agilent Technologies, Palo Alto, CA).",9606,"Total RNA from 20 lung cell lines representing all major histological types of lung cancers, labeled with Cyanine-3 (green).",Homo sapiens,n/a,total RNA,"Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 250 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.",Cy3,"cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescent Linear Amplification kit (Agilent Technologies, Palo Alto, CA).",9606,"Cy5-sample cRNA and Cy3-common reference cRNA were hybridized to a custom Agilent oligonucleotide microarray, containing a total of 21,619 spots corresponding to 18,175 unique genes, followed by confocal laser scanning (Agilent Technologies).",Scanned on an Agilent G2565AA scanner.,Images were quantified using Agilent Feature Extraction Software (version A.7.5).,n/a,"LOWESS normalized, background subtracted VALUE data obtained from log10 of processed Red signal/processed Green signal. Agilent software was used.",GPL7015,"Takashi,,Takahashi",Aichi Cancer Center,"1-1 Kanokoden, Chikusa-ku",Nagoya,Aichi,464-8681,Japan,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM303nnn/GSM303004/suppl/GSM303004.txt.gz,21619,47,AD009,-,Mut,Y,TRU-a,,Poorly,AD,Definite,Wt,Positive,Wt,85,59,IIIA,T2N2M0,F,"Liver, adrenal",120,Dead,511
GSM303005,Patient 010 with adenocarcinoma,GSM303005,Public on Apr 01 2009,Jul 02 2008,Jul 02 2008,RNA,2,Primary lung tumor,Homo sapiens,Annotation: AD010,Position in Figure 1 (L to R): 72,Age: 60,Sex: F,Histology: AD,Smoking (BI): 150,pTNM: T1N0M0,pStage: IA,Status: Alive,Survival (days): 3245,Evidence of relapse: N,Site of relapse:,EGFR status: Wt,K-ras Status: Wt,p53 Status: Wt,Gefitinib treatment:,Position in Figure 2 (L to R): 49,Expression profile-based classification: TRU-a,Invasion: Not obvious,Necrosis: Negative,Grade: Well,BAC features: +,total RNA,"Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 250 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.",Cy5,"cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescent Linear Amplification kit (Agilent Technologies, Palo Alto, CA).",9606,"Total RNA from 20 lung cell lines representing all major histological types of lung cancers, labeled with Cyanine-3 (green).",Homo sapiens,n/a,total RNA,"Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 250 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.",Cy3,"cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescent Linear Amplification kit (Agilent Technologies, Palo Alto, CA).",9606,"Cy5-sample cRNA and Cy3-common reference cRNA were hybridized to a custom Agilent oligonucleotide microarray, containing a total of 21,619 spots corresponding to 18,175 unique genes, followed by confocal laser scanning (Agilent Technologies).",Scanned on an Agilent G2565AA scanner.,Images were quantified using Agilent Feature Extraction Software (version A.7.5).,n/a,"LOWESS normalized, background subtracted VALUE data obtained from log10 of processed Red signal/processed Green signal. Agilent software was used.",GPL7015,"Takashi,,Takahashi",Aichi Cancer Center,"1-1 Kanokoden, Chikusa-ku",Nagoya,Aichi,464-8681,Japan,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM303nnn/GSM303005/suppl/GSM303005.txt.gz,21619,60,AD010,+,Wt,N,TRU-a,,Well,AD,Not obvious,Wt,Negative,Wt,72,49,IA,T1N0M0,F,,150,Alive,3245
GSM303006,Patient 011 with adenocarcinoma,GSM303006,Public on Apr 01 2009,Jul 02 2008,Jul 02 2008,RNA,2,Primary lung tumor,Homo sapiens,Annotation: AD011,Position in Figure 1 (L to R): 142,Age: 64,Sex: F,Histology: AD,Smoking (BI): 0,pTNM: T2N0M0,pStage: IB,Status: Alive,Survival (days): 3295,Evidence of relapse: Y,Site of relapse: PM,EGFR status: Mut,K-ras Status: Wt,p53 Status: Wt,Gefitinib treatment:,Position in Figure 2 (L to R): 73,Expression profile-based classification: TRU-b,Invasion: Definite but focal,Necrosis: Negative,Grade: Moderately,BAC features: -,total RNA,"Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 250 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.",Cy5,"cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescent Linear Amplification kit (Agilent Technologies, Palo Alto, CA).",9606,"Total RNA from 20 lung cell lines representing all major histological types of lung cancers, labeled with Cyanine-3 (green).",Homo sapiens,n/a,total RNA,"Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 250 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.",Cy3,"cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescent Linear Amplification kit (Agilent Technologies, Palo Alto, CA).",9606,"Cy5-sample cRNA and Cy3-common reference cRNA were hybridized to a custom Agilent oligonucleotide microarray, containing a total of 21,619 spots corresponding to 18,175 unique genes, followed by confocal laser scanning (Agilent Technologies).",Scanned on an Agilent G2565AA scanner.,Images were quantified using Agilent Feature Extraction Software (version A.7.5).,n/a,"LOWESS normalized, background subtracted VALUE data obtained from log10 of processed Red signal/processed Green signal. Agilent software was used.",GPL7015,"Takashi,,Takahashi",Aichi Cancer Center,"1-1 Kanokoden, Chikusa-ku",Nagoya,Aichi,464-8681,Japan,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM303nnn/GSM303006/suppl/GSM303006.txt.gz,21619,64,AD011,-,Mut,Y,TRU-b,,Moderately,AD,Definite but focal,Wt,Negative,Wt,142,73,IB,T2N0M0,F,PM,0,Alive,3295
GSM303007,Patient 012 with adenocarcinoma,GSM303007,Public on Apr 01 2009,Jul 02 2008,Jul 02 2008,RNA,2,Primary lung tumor,Homo sapiens,Annotation: AD012,Position in Figure 1 (L to R): 102,Age: 57,Sex: M,Histology: AD,Smoking (BI): 1110,pTNM: T2N2M0,pStage: IIIA,Status: Alive,Survival (days): 3260,Evidence of relapse: N,Site of relapse:,EGFR status: Mut,K-ras Status: Wt,p53 Status: Mut,Gefitinib treatment:,Position in Figure 2 (L to R): 12,Expression profile-based classification: Non-TRU,Invasion: Definite,Necrosis: Focal,Grade: Moderately,BAC features: -,total RNA,"Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 250 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.",Cy5,"cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescent Linear Amplification kit (Agilent Technologies, Palo Alto, CA).",9606,"Total RNA from 20 lung cell lines representing all major histological types of lung cancers, labeled with Cyanine-3 (green).",Homo sapiens,n/a,total RNA,"Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 250 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.",Cy3,"cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescent Linear Amplification kit (Agilent Technologies, Palo Alto, CA).",9606,"Cy5-sample cRNA and Cy3-common reference cRNA were hybridized to a custom Agilent oligonucleotide microarray, containing a total of 21,619 spots corresponding to 18,175 unique genes, followed by confocal laser scanning (Agilent Technologies).",Scanned on an Agilent G2565AA scanner.,Images were quantified using Agilent Feature Extraction Software (version A.7.5).,n/a,"LOWESS normalized, background subtracted VALUE data obtained from log10 of processed Red signal/processed Green signal. Agilent software was used.",GPL7015,"Takashi,,Takahashi",Aichi Cancer Center,"1-1 Kanokoden, Chikusa-ku",Nagoya,Aichi,464-8681,Japan,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM303nnn/GSM303007/suppl/GSM303007.txt.gz,21619,57,AD012,-,Mut,N,Non-TRU,,Moderately,AD,Definite,Wt,Focal,Mut,102,12,IIIA,T2N2M0,M,,1110,Alive,3260
GSM303008,Patient 013 with adenocarcinoma,GSM303008,Public on Apr 01 2009,Jul 02 2008,Jul 02 2008,RNA,2,Primary lung tumor,Homo sapiens,Annotation: AD013,Position in Figure 1 (L to R): 117,Age: 55,Sex: F,Histology: AD,Smoking (BI): 0,pTNM: T3N0M0,pStage: IIB,Status: Dead,Survival (days): 1855,Evidence of relapse: Y,Site of relapse: Liver,EGFR status: Mut,K-ras Status: Wt,p53 Status: Mut,Gefitinib treatment:,Position in Figure 2 (L to R): 89,Expression profile-based classification: TRU-b,Invasion: Definite,Necrosis: Positive,Grade: Moderately,BAC features: -,total RNA,"Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 250 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.",Cy5,"cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescent Linear Amplification kit (Agilent Technologies, Palo Alto, CA).",9606,"Total RNA from 20 lung cell lines representing all major histological types of lung cancers, labeled with Cyanine-3 (green).",Homo sapiens,n/a,total RNA,"Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 250 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.",Cy3,"cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescent Linear Amplification kit (Agilent Technologies, Palo Alto, CA).",9606,"Cy5-sample cRNA and Cy3-common reference cRNA were hybridized to a custom Agilent oligonucleotide microarray, containing a total of 21,619 spots corresponding to 18,175 unique genes, followed by confocal laser scanning (Agilent Technologies).",Scanned on an Agilent G2565AA scanner.,Images were quantified using Agilent Feature Extraction Software (version A.7.5).,n/a,"LOWESS normalized, background subtracted VALUE data obtained from log10 of processed Red signal/processed Green signal. Agilent software was used.",GPL7015,"Takashi,,Takahashi",Aichi Cancer Center,"1-1 Kanokoden, Chikusa-ku",Nagoya,Aichi,464-8681,Japan,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM303nnn/GSM303008/suppl/GSM303008.txt.gz,21619,55,AD013,-,Mut,Y,TRU-b,,Moderately,AD,Definite,Wt,Positive,Mut,117,89,IIB,T3N0M0,F,Liver,0,Dead,1855
GSM303009,Patient 014 with adenocarcinoma,GSM303009,Public on Apr 01 2009,Jul 02 2008,Jul 02 2008,RNA,2,Primary lung tumor,Homo sapiens,Annotation: AD014,Position in Figure 1 (L to R): 118,Age: 74,Sex: M,Histology: AD,Smoking (BI): 810,pTNM: T1N2M0,pStage: IIIA,Status: Dead,Survival (days): 694,Evidence of relapse: Y,Site of relapse: LN (mediastinal),EGFR status: Wt,K-ras Status: Mut,p53 Status: Wt,Gefitinib treatment:,Position in Figure 2 (L to R): 5,Expression profile-based classification: Non-TRU,Invasion: Definite,Necrosis: Negative,Grade: Well,BAC features: +,total RNA,"Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 250 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.",Cy5,"cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescent Linear Amplification kit (Agilent Technologies, Palo Alto, CA).",9606,"Total RNA from 20 lung cell lines representing all major histological types of lung cancers, labeled with Cyanine-3 (green).",Homo sapiens,n/a,total RNA,"Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 250 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.",Cy3,"cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescent Linear Amplification kit (Agilent Technologies, Palo Alto, CA).",9606,"Cy5-sample cRNA and Cy3-common reference cRNA were hybridized to a custom Agilent oligonucleotide microarray, containing a total of 21,619 spots corresponding to 18,175 unique genes, followed by confocal laser scanning (Agilent Technologies).",Scanned on an Agilent G2565AA scanner.,Images were quantified using Agilent Feature Extraction Software (version A.7.5).,n/a,"LOWESS normalized, background subtracted VALUE data obtained from log10 of processed Red signal/processed Green signal. Agilent software was used.",GPL7015,"Takashi,,Takahashi",Aichi Cancer Center,"1-1 Kanokoden, Chikusa-ku",Nagoya,Aichi,464-8681,Japan,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM303nnn/GSM303009/suppl/GSM303009.txt.gz,21619,74,AD014,+,Wt,Y,Non-TRU,,Well,AD,Definite,Mut,Negative,Wt,118,5,IIIA,T1N2M0,M,LN (mediastinal),810,Dead,694
GSM303010,Patient 015 with adenocarcinoma,GSM303010,Public on Apr 01 2009,Jul 02 2008,Jul 02 2008,RNA,2,Primary lung tumor,Homo sapiens,Annotation: AD015,Position in Figure 1 (L to R): 78,Age: 61,Sex: M,Histology: AD,Smoking (BI): 1230,pTNM: T1N0M0,pStage: IA,Status: Alive,Survival (days): 3246,Evidence of relapse: N,Site of relapse:,EGFR status: Wt,K-ras Status: Wt,p53 Status: Wt,Gefitinib treatment:,Position in Figure 2 (L to R): 62,Expression profile-based classification: TRU-a,Invasion: Definite,Necrosis: Negative,Grade: Poorly,BAC features: -,total RNA,"Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 250 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.",Cy5,"cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescent Linear Amplification kit (Agilent Technologies, Palo Alto, CA).",9606,"Total RNA from 20 lung cell lines representing all major histological types of lung cancers, labeled with Cyanine-3 (green).",Homo sapiens,n/a,total RNA,"Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 250 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.",Cy3,"cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescent Linear Amplification kit (Agilent Technologies, Palo Alto, CA).",9606,"Cy5-sample cRNA and Cy3-common reference cRNA were hybridized to a custom Agilent oligonucleotide microarray, containing a total of 21,619 spots corresponding to 18,175 unique genes, followed by confocal laser scanning (Agilent Technologies).",Scanned on an Agilent G2565AA scanner.,Images were quantified using Agilent Feature Extraction Software (version A.7.5).,n/a,"LOWESS normalized, background subtracted VALUE data obtained from log10 of processed Red signal/processed Green signal. Agilent software was used.",GPL7015,"Takashi,,Takahashi",Aichi Cancer Center,"1-1 Kanokoden, Chikusa-ku",Nagoya,Aichi,464-8681,Japan,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM303nnn/GSM303010/suppl/GSM303010.txt.gz,21619,61,AD015,-,Wt,N,TRU-a,,Poorly,AD,Definite,Wt,Negative,Wt,78,62,IA,T1N0M0,M,,1230,Alive,3246
GSM303011,Patient 016 with adenocarcinoma,GSM303011,Public on Apr 01 2009,Jul 02 2008,Jul 02 2008,RNA,2,Primary lung tumor,Homo sapiens,Annotation: AD016,Position in Figure 1 (L to R): 57,Age: 67,Sex: F,Histology: AD,Smoking (BI): 200,pTNM: T2N0M0,pStage: IB,Status: Alive,Survival (days): 3169,Evidence of relapse: N,Site of relapse:,EGFR status: Wt,K-ras Status: Wt,p53 Status: Mut,Gefitinib treatment:,Position in Figure 2 (L to R): 57,Expression profile-based classification: TRU-a,Invasion: Definite,Necrosis: Positive,Grade: Moderately,BAC features: -,total RNA,"Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 250 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.",Cy5,"cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescent Linear Amplification kit (Agilent Technologies, Palo Alto, CA).",9606,"Total RNA from 20 lung cell lines representing all major histological types of lung cancers, labeled with Cyanine-3 (green).",Homo sapiens,n/a,total RNA,"Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 250 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.",Cy3,"cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescent Linear Amplification kit (Agilent Technologies, Palo Alto, CA).",9606,"Cy5-sample cRNA and Cy3-common reference cRNA were hybridized to a custom Agilent oligonucleotide microarray, containing a total of 21,619 spots corresponding to 18,175 unique genes, followed by confocal laser scanning (Agilent Technologies).",Scanned on an Agilent G2565AA scanner.,Images were quantified using Agilent Feature Extraction Software (version A.7.5).,n/a,"LOWESS normalized, background subtracted VALUE data obtained from log10 of processed Red signal/processed Green signal. Agilent software was used.",GPL7015,"Takashi,,Takahashi",Aichi Cancer Center,"1-1 Kanokoden, Chikusa-ku",Nagoya,Aichi,464-8681,Japan,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM303nnn/GSM303011/suppl/GSM303011.txt.gz,21619,67,AD016,-,Wt,N,TRU-a,,Moderately,AD,Definite,Wt,Positive,Mut,57,57,IB,T2N0M0,F,,200,Alive,3169
GSM303012,Patient 017 with adenocarcinoma,GSM303012,Public on Apr 01 2009,Jul 02 2008,Jul 02 2008,RNA,2,Primary lung tumor,Homo sapiens,Annotation: AD017,Position in Figure 1 (L to R): 59,Age: 63,Sex: F,Histology: AD,Smoking (BI): 0,pTNM: T1N0M0,pStage: IA,Status: Alive,Survival (days): 3161,Evidence of relapse: N,Site of relapse:,EGFR status: Wt,K-ras Status: Wt,p53 Status: Mut,Gefitinib treatment:,Position in Figure 2 (L to R): 43,Expression profile-based classification: TRU-a,Invasion: Definite,Necrosis: Negative,Grade: Poorly,BAC features: -,total RNA,"Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 250 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.",Cy5,"cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescent Linear Amplification kit (Agilent Technologies, Palo Alto, CA).",9606,"Total RNA from 20 lung cell lines representing all major histological types of lung cancers, labeled with Cyanine-3 (green).",Homo sapiens,n/a,total RNA,"Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 250 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.",Cy3,"cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescent Linear Amplification kit (Agilent Technologies, Palo Alto, CA).",9606,"Cy5-sample cRNA and Cy3-common reference cRNA were hybridized to a custom Agilent oligonucleotide microarray, containing a total of 21,619 spots corresponding to 18,175 unique genes, followed by confocal laser scanning (Agilent Technologies).",Scanned on an Agilent G2565AA scanner.,Images were quantified using Agilent Feature Extraction Software (version A.7.5).,n/a,"LOWESS normalized, background subtracted VALUE data obtained from log10 of processed Red signal/processed Green signal. Agilent software was used.",GPL7015,"Takashi,,Takahashi",Aichi Cancer Center,"1-1 Kanokoden, Chikusa-ku",Nagoya,Aichi,464-8681,Japan,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM303nnn/GSM303012/suppl/GSM303012.txt.gz,21619,63,AD017,-,Wt,N,TRU-a,,Poorly,AD,Definite,Wt,Negative,Mut,59,43,IA,T1N0M0,F,,0,Alive,3161
GSM303013,Patient 018 with adenocarcinoma,GSM303013,Public on Apr 01 2009,Jul 02 2008,Jul 02 2008,RNA,2,Primary lung tumor,Homo sapiens,Annotation: AD018,Position in Figure 1 (L to R): 65,Age: 59,Sex: M,Histology: AD,Smoking (BI): 0,pTNM: T2N0M0,pStage: IB,Status: Dead,Survival (days): 1030,Evidence of relapse: Y,Site of relapse: Local rec.,EGFR status: Wt,K-ras Status: Wt,p53 Status: Wt,Gefitinib treatment:,Position in Figure 2 (L to R): 44,Expression profile-based classification: TRU-a,Invasion: Definite but focal,Necrosis: Negative,Grade: Well,BAC features: +,total RNA,"Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 250 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.",Cy5,"cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescent Linear Amplification kit (Agilent Technologies, Palo Alto, CA).",9606,"Total RNA from 20 lung cell lines representing all major histological types of lung cancers, labeled with Cyanine-3 (green).",Homo sapiens,n/a,total RNA,"Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 250 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.",Cy3,"cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescent Linear Amplification kit (Agilent Technologies, Palo Alto, CA).",9606,"Cy5-sample cRNA and Cy3-common reference cRNA were hybridized to a custom Agilent oligonucleotide microarray, containing a total of 21,619 spots corresponding to 18,175 unique genes, followed by confocal laser scanning (Agilent Technologies).",Scanned on an Agilent G2565AA scanner.,Images were quantified using Agilent Feature Extraction Software (version A.7.5).,n/a,"LOWESS normalized, background subtracted VALUE data obtained from log10 of processed Red signal/processed Green signal. Agilent software was used.",GPL7015,"Takashi,,Takahashi",Aichi Cancer Center,"1-1 Kanokoden, Chikusa-ku",Nagoya,Aichi,464-8681,Japan,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM303nnn/GSM303013/suppl/GSM303013.txt.gz,21619,59,AD018,+,Wt,Y,TRU-a,,Well,AD,Definite but focal,Wt,Negative,Wt,65,44,IB,T2N0M0,M,Local rec.,0,Dead,1030
GSM303014,Patient 019 with adenocarcinoma,GSM303014,Public on Apr 01 2009,Jul 02 2008,Jul 02 2008,RNA,2,Primary lung tumor,Homo sapiens,Annotation: AD019,Position in Figure 1 (L to R): 92,Age: 66,Sex: M,Histology: AD,Smoking (BI): 1040,pTNM: T1N2M0,pStage: IIIA,Status: Dead,Survival (days): 2102,Evidence of relapse: Y,Site of relapse: LN (mediastinal),EGFR status: Wt,K-ras Status: Wt,p53 Status: Wt,Gefitinib treatment:,Position in Figure 2 (L to R): 67,Expression profile-based classification: TRU-a,Invasion: Definite,Necrosis: Focal,Grade: Poorly,BAC features: -,total RNA,"Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 250 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.",Cy5,"cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescent Linear Amplification kit (Agilent Technologies, Palo Alto, CA).",9606,"Total RNA from 20 lung cell lines representing all major histological types of lung cancers, labeled with Cyanine-3 (green).",Homo sapiens,n/a,total RNA,"Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 250 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.",Cy3,"cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescent Linear Amplification kit (Agilent Technologies, Palo Alto, CA).",9606,"Cy5-sample cRNA and Cy3-common reference cRNA were hybridized to a custom Agilent oligonucleotide microarray, containing a total of 21,619 spots corresponding to 18,175 unique genes, followed by confocal laser scanning (Agilent Technologies).",Scanned on an Agilent G2565AA scanner.,Images were quantified using Agilent Feature Extraction Software (version A.7.5).,n/a,"LOWESS normalized, background subtracted VALUE data obtained from log10 of processed Red signal/processed Green signal. Agilent software was used.",GPL7015,"Takashi,,Takahashi",Aichi Cancer Center,"1-1 Kanokoden, Chikusa-ku",Nagoya,Aichi,464-8681,Japan,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM303nnn/GSM303014/suppl/GSM303014.txt.gz,21619,66,AD019,-,Wt,Y,TRU-a,,Poorly,AD,Definite,Wt,Focal,Wt,92,67,IIIA,T1N2M0,M,LN (mediastinal),1040,Dead,2102
GSM303015,Patient 020 with adenocarcinoma,GSM303015,Public on Apr 01 2009,Jul 02 2008,Jul 02 2008,RNA,2,Primary lung tumor,Homo sapiens,Annotation: AD020,Position in Figure 1 (L to R): 133,Age: 68,Sex: F,Histology: AD,Smoking (BI): 0,pTNM: T2N2M0,pStage: IIIA,Status: Alive,Survival (days): 3057,Evidence of relapse: N,Site of relapse:,EGFR status: Wt,K-ras Status: Wt,p53 Status: Wt,Gefitinib treatment:,Position in Figure 2 (L to R): 85,Expression profile-based classification: TRU-b,Invasion: Definite,Necrosis: Negative,Grade: Moderately,BAC features: +,total RNA,"Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 250 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.",Cy5,"cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescent Linear Amplification kit (Agilent Technologies, Palo Alto, CA).",9606,"Total RNA from 20 lung cell lines representing all major histological types of lung cancers, labeled with Cyanine-3 (green).",Homo sapiens,n/a,total RNA,"Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 250 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.",Cy3,"cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescent Linear Amplification kit (Agilent Technologies, Palo Alto, CA).",9606,"Cy5-sample cRNA and Cy3-common reference cRNA were hybridized to a custom Agilent oligonucleotide microarray, containing a total of 21,619 spots corresponding to 18,175 unique genes, followed by confocal laser scanning (Agilent Technologies).",Scanned on an Agilent G2565AA scanner.,Images were quantified using Agilent Feature Extraction Software (version A.7.5).,n/a,"LOWESS normalized, background subtracted VALUE data obtained from log10 of processed Red signal/processed Green signal. Agilent software was used.",GPL7015,"Takashi,,Takahashi",Aichi Cancer Center,"1-1 Kanokoden, Chikusa-ku",Nagoya,Aichi,464-8681,Japan,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM303nnn/GSM303015/suppl/GSM303015.txt.gz,21619,68,AD020,+,Wt,N,TRU-b,,Moderately,AD,Definite,Wt,Negative,Wt,133,85,IIIA,T2N2M0,F,,0,Alive,3057
GSM303016,Patient 021 with adenocarcinoma,GSM303016,Public on Apr 01 2009,Jul 02 2008,Jul 02 2008,RNA,2,Primary lung tumor,Homo sapiens,Annotation: AD021,Position in Figure 1 (L to R): 77,Age: 64,Sex: M,Histology: AD,Smoking (BI): 0,pTNM: T1N0M0,pStage: IA,Status: Alive,Survival (days): 3182,Evidence of relapse: N,Site of relapse:,EGFR status: Wt,K-ras Status: Wt,p53 Status: Mut,Gefitinib treatment:,Position in Figure 2 (L to R): 61,Expression profile-based classification: TRU-a,Invasion: Definite,Necrosis: Negative,Grade: Moderately,BAC features: +,total RNA,"Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 250 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.",Cy5,"cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescent Linear Amplification kit (Agilent Technologies, Palo Alto, CA).",9606,"Total RNA from 20 lung cell lines representing all major histological types of lung cancers, labeled with Cyanine-3 (green).",Homo sapiens,n/a,total RNA,"Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 250 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.",Cy3,"cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescent Linear Amplification kit (Agilent Technologies, Palo Alto, CA).",9606,"Cy5-sample cRNA and Cy3-common reference cRNA were hybridized to a custom Agilent oligonucleotide microarray, containing a total of 21,619 spots corresponding to 18,175 unique genes, followed by confocal laser scanning (Agilent Technologies).",Scanned on an Agilent G2565AA scanner.,Images were quantified using Agilent Feature Extraction Software (version A.7.5).,n/a,"LOWESS normalized, background subtracted VALUE data obtained from log10 of processed Red signal/processed Green signal. Agilent software was used.",GPL7015,"Takashi,,Takahashi",Aichi Cancer Center,"1-1 Kanokoden, Chikusa-ku",Nagoya,Aichi,464-8681,Japan,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM303nnn/GSM303016/suppl/GSM303016.txt.gz,21619,64,AD021,+,Wt,N,TRU-a,,Moderately,AD,Definite,Wt,Negative,Mut,77,61,IA,T1N0M0,M,,0,Alive,3182
GSM303017,Patient 022 with adenocarcinoma,GSM303017,Public on Apr 01 2009,Jul 02 2008,Jul 02 2008,RNA,2,Primary lung tumor,Homo sapiens,Annotation: AD022,Position in Figure 1 (L to R): 66,Age: 70,Sex: F,Histology: AD,Smoking (BI): 0,pTNM: T1N0M0,pStage: IA,Status: Alive,Survival (days): 3009,Evidence of relapse: N,Site of relapse:,EGFR status: Wt,K-ras Status: Wt,p53 Status: Wt,Gefitinib treatment:,Position in Figure 2 (L to R): 79,Expression profile-based classification: TRU-b,Invasion: Definite but focal,Necrosis: Negative,Grade: Well,BAC features: +,total RNA,"Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 250 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.",Cy5,"cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescent Linear Amplification kit (Agilent Technologies, Palo Alto, CA).",9606,"Total RNA from 20 lung cell lines representing all major histological types of lung cancers, labeled with Cyanine-3 (green).",Homo sapiens,n/a,total RNA,"Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 250 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.",Cy3,"cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescent Linear Amplification kit (Agilent Technologies, Palo Alto, CA).",9606,"Cy5-sample cRNA and Cy3-common reference cRNA were hybridized to a custom Agilent oligonucleotide microarray, containing a total of 21,619 spots corresponding to 18,175 unique genes, followed by confocal laser scanning (Agilent Technologies).",Scanned on an Agilent G2565AA scanner.,Images were quantified using Agilent Feature Extraction Software (version A.7.5).,n/a,"LOWESS normalized, background subtracted VALUE data obtained from log10 of processed Red signal/processed Green signal. Agilent software was used.",GPL7015,"Takashi,,Takahashi",Aichi Cancer Center,"1-1 Kanokoden, Chikusa-ku",Nagoya,Aichi,464-8681,Japan,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM303nnn/GSM303017/suppl/GSM303017.txt.gz,21619,70,AD022,+,Wt,N,TRU-b,,Well,AD,Definite but focal,Wt,Negative,Wt,66,79,IA,T1N0M0,F,,0,Alive,3009
GSM303018,Patient 023 with adenocarcinoma,GSM303018,Public on Apr 01 2009,Jul 02 2008,Jul 02 2008,RNA,2,Primary lung tumor,Homo sapiens,Annotation: AD023,Position in Figure 1 (L to R): 62,Age: 43,Sex: M,Histology: AD,Smoking (BI): 0,pTNM: T2N0M0,pStage: IB,Status: Alive,Survival (days): 3004,Evidence of relapse: N,Site of relapse:,EGFR status: Wt,K-ras Status: Wt,p53 Status: Wt,Gefitinib treatment:,Position in Figure 2 (L to R): 71,Expression profile-based classification: TRU-a,Invasion: Definite,Necrosis: Negative,Grade: Moderately,BAC features: -,total RNA,"Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 250 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.",Cy5,"cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescent Linear Amplification kit (Agilent Technologies, Palo Alto, CA).",9606,"Total RNA from 20 lung cell lines representing all major histological types of lung cancers, labeled with Cyanine-3 (green).",Homo sapiens,n/a,total RNA,"Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 250 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.",Cy3,"cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescent Linear Amplification kit (Agilent Technologies, Palo Alto, CA).",9606,"Cy5-sample cRNA and Cy3-common reference cRNA were hybridized to a custom Agilent oligonucleotide microarray, containing a total of 21,619 spots corresponding to 18,175 unique genes, followed by confocal laser scanning (Agilent Technologies).",Scanned on an Agilent G2565AA scanner.,Images were quantified using Agilent Feature Extraction Software (version A.7.5).,n/a,"LOWESS normalized, background subtracted VALUE data obtained from log10 of processed Red signal/processed Green signal. Agilent software was used.",GPL7015,"Takashi,,Takahashi",Aichi Cancer Center,"1-1 Kanokoden, Chikusa-ku",Nagoya,Aichi,464-8681,Japan,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM303nnn/GSM303018/suppl/GSM303018.txt.gz,21619,43,AD023,-,Wt,N,TRU-a,,Moderately,AD,Definite,Wt,Negative,Wt,62,71,IB,T2N0M0,M,,0,Alive,3004
GSM303019,Patient 024 with adenocarcinoma,GSM303019,Public on Apr 01 2009,Jul 02 2008,Jul 02 2008,RNA,2,Primary lung tumor,Homo sapiens,Annotation: AD024,Position in Figure 1 (L to R): 70,Age: 73,Sex: M,Histology: AD,Smoking (BI): 430,pTNM: T1N2M0,pStage: IIIA,Status: Alive,Survival (days): 3170,Evidence of relapse: N,Site of relapse:,EGFR status: Wt,K-ras Status: Wt,p53 Status: Wt,Gefitinib treatment:,Position in Figure 2 (L to R): 58,Expression profile-based classification: TRU-a,Invasion: Definite,Necrosis: Negative,Grade: Poorly,BAC features: -,total RNA,"Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 250 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.",Cy5,"cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescent Linear Amplification kit (Agilent Technologies, Palo Alto, CA).",9606,"Total RNA from 20 lung cell lines representing all major histological types of lung cancers, labeled with Cyanine-3 (green).",Homo sapiens,n/a,total RNA,"Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 250 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.",Cy3,"cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescent Linear Amplification kit (Agilent Technologies, Palo Alto, CA).",9606,"Cy5-sample cRNA and Cy3-common reference cRNA were hybridized to a custom Agilent oligonucleotide microarray, containing a total of 21,619 spots corresponding to 18,175 unique genes, followed by confocal laser scanning (Agilent Technologies).",Scanned on an Agilent G2565AA scanner.,Images were quantified using Agilent Feature Extraction Software (version A.7.5).,n/a,"LOWESS normalized, background subtracted VALUE data obtained from log10 of processed Red signal/processed Green signal. Agilent software was used.",GPL7015,"Takashi,,Takahashi",Aichi Cancer Center,"1-1 Kanokoden, Chikusa-ku",Nagoya,Aichi,464-8681,Japan,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM303nnn/GSM303019/suppl/GSM303019.txt.gz,21619,73,AD024,-,Wt,N,TRU-a,,Poorly,AD,Definite,Wt,Negative,Wt,70,58,IIIA,T1N2M0,M,,430,Alive,3170
GSM303020,Patient 025 with adenocarcinoma,GSM303020,Public on Apr 01 2009,Jul 02 2008,Jul 02 2008,RNA,2,Primary lung tumor,Homo sapiens,Annotation: AD025,Position in Figure 1 (L to R): 149,Age: 72,Sex: M,Histology: AD,Smoking (BI): 636,pTNM: T2N0M0,pStage: IB,Status: Alive,Survival (days): 2974,Evidence of relapse: N,Site of relapse:,EGFR status: Wt,K-ras Status: Wt,p53 Status: Mut,Gefitinib treatment:,Position in Figure 2 (L to R): 32,Expression profile-based classification: Non-TRU,Invasion: Definite,Necrosis: Positive,Grade: Moderately,BAC features: -,total RNA,"Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 250 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.",Cy5,"cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescent Linear Amplification kit (Agilent Technologies, Palo Alto, CA).",9606,"Total RNA from 20 lung cell lines representing all major histological types of lung cancers, labeled with Cyanine-3 (green).",Homo sapiens,n/a,total RNA,"Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 250 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.",Cy3,"cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescent Linear Amplification kit (Agilent Technologies, Palo Alto, CA).",9606,"Cy5-sample cRNA and Cy3-common reference cRNA were hybridized to a custom Agilent oligonucleotide microarray, containing a total of 21,619 spots corresponding to 18,175 unique genes, followed by confocal laser scanning (Agilent Technologies).",Scanned on an Agilent G2565AA scanner.,Images were quantified using Agilent Feature Extraction Software (version A.7.5).,n/a,"LOWESS normalized, background subtracted VALUE data obtained from log10 of processed Red signal/processed Green signal. Agilent software was used.",GPL7015,"Takashi,,Takahashi",Aichi Cancer Center,"1-1 Kanokoden, Chikusa-ku",Nagoya,Aichi,464-8681,Japan,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM303nnn/GSM303020/suppl/GSM303020.txt.gz,21619,72,AD025,-,Wt,N,Non-TRU,,Moderately,AD,Definite,Wt,Positive,Mut,149,32,IB,T2N0M0,M,,636,Alive,2974
GSM303021,Patient 026 with adenocarcinoma,GSM303021,Public on Apr 01 2009,Jul 02 2008,Jul 02 2008,RNA,2,Primary lung tumor,Homo sapiens,Annotation: AD026,Position in Figure 1 (L to R): 68,Age: 56,Sex: M,Histology: AD,Smoking (BI): 1200,pTNM: T1N0M0,pStage: IA,Status: Alive,Survival (days): 2879,Evidence of relapse: N,Site of relapse:,EGFR status: Mut,K-ras Status: Wt,p53 Status: Wt,Gefitinib treatment:,Position in Figure 2 (L to R): 81,Expression profile-based classification: TRU-b,Invasion: Negative,Necrosis: Negative,Grade: Well,BAC features: +,total RNA,"Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 250 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.",Cy5,"cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescent Linear Amplification kit (Agilent Technologies, Palo Alto, CA).",9606,"Total RNA from 20 lung cell lines representing all major histological types of lung cancers, labeled with Cyanine-3 (green).",Homo sapiens,n/a,total RNA,"Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 250 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.",Cy3,"cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescent Linear Amplification kit (Agilent Technologies, Palo Alto, CA).",9606,"Cy5-sample cRNA and Cy3-common reference cRNA were hybridized to a custom Agilent oligonucleotide microarray, containing a total of 21,619 spots corresponding to 18,175 unique genes, followed by confocal laser scanning (Agilent Technologies).",Scanned on an Agilent G2565AA scanner.,Images were quantified using Agilent Feature Extraction Software (version A.7.5).,n/a,"LOWESS normalized, background subtracted VALUE data obtained from log10 of processed Red signal/processed Green signal. Agilent software was used.",GPL7015,"Takashi,,Takahashi",Aichi Cancer Center,"1-1 Kanokoden, Chikusa-ku",Nagoya,Aichi,464-8681,Japan,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM303nnn/GSM303021/suppl/GSM303021.txt.gz,21619,56,AD026,+,Mut,N,TRU-b,,Well,AD,Negative,Wt,Negative,Wt,68,81,IA,T1N0M0,M,,1200,Alive,2879
GSM303022,Patient 027 with adenocarcinoma,GSM303022,Public on Apr 01 2009,Jul 02 2008,Jul 02 2008,RNA,2,Primary lung tumor,Homo sapiens,Annotation: AD027,Position in Figure 1 (L to R): 63,Age: 75,Sex: M,Histology: AD,Smoking (BI): 0,pTNM: T3N0M0,pStage: IIB,Status: Dead,Survival (days): 1271,Evidence of relapse: Y,Site of relapse: PM,EGFR status: Mut,K-ras Status: Wt,p53 Status: Wt,Gefitinib treatment:,Position in Figure 2 (L to R): 63,Expression profile-based classification: TRU-a,Invasion: Definite,Necrosis: Negative,Grade: Poorly,BAC features: -,total RNA,"Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 250 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.",Cy5,"cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescent Linear Amplification kit (Agilent Technologies, Palo Alto, CA).",9606,"Total RNA from 20 lung cell lines representing all major histological types of lung cancers, labeled with Cyanine-3 (green).",Homo sapiens,n/a,total RNA,"Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 250 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.",Cy3,"cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescent Linear Amplification kit (Agilent Technologies, Palo Alto, CA).",9606,"Cy5-sample cRNA and Cy3-common reference cRNA were hybridized to a custom Agilent oligonucleotide microarray, containing a total of 21,619 spots corresponding to 18,175 unique genes, followed by confocal laser scanning (Agilent Technologies).",Scanned on an Agilent G2565AA scanner.,Images were quantified using Agilent Feature Extraction Software (version A.7.5).,n/a,"LOWESS normalized, background subtracted VALUE data obtained from log10 of processed Red signal/processed Green signal. Agilent software was used.",GPL7015,"Takashi,,Takahashi",Aichi Cancer Center,"1-1 Kanokoden, Chikusa-ku",Nagoya,Aichi,464-8681,Japan,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM303nnn/GSM303022/suppl/GSM303022.txt.gz,21619,75,AD027,-,Mut,Y,TRU-a,,Poorly,AD,Definite,Wt,Negative,Wt,63,63,IIB,T3N0M0,M,PM,0,Dead,1271
GSM303023,Patient 028 with adenocarcinoma,GSM303023,Public on Apr 01 2009,Jul 02 2008,Jul 02 2008,RNA,2,Primary lung tumor,Homo sapiens,Annotation: AD028,Position in Figure 1 (L to R): 69,Age: 61,Sex: M,Histology: AD,Smoking (BI): 150,pTNM: T1N0M0,pStage: IA,Status: Alive,Survival (days): 2873,Evidence of relapse: N,Site of relapse:,EGFR status: Wt,K-ras Status: Wt,p53 Status: Wt,Gefitinib treatment:,Position in Figure 2 (L to R): 78,Expression profile-based classification: TRU-b,Invasion: Not obvious,Necrosis: Negative,Grade: Well,BAC features: +,total RNA,"Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 250 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.",Cy5,"cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescent Linear Amplification kit (Agilent Technologies, Palo Alto, CA).",9606,"Total RNA from 20 lung cell lines representing all major histological types of lung cancers, labeled with Cyanine-3 (green).",Homo sapiens,n/a,total RNA,"Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 250 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.",Cy3,"cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescent Linear Amplification kit (Agilent Technologies, Palo Alto, CA).",9606,"Cy5-sample cRNA and Cy3-common reference cRNA were hybridized to a custom Agilent oligonucleotide microarray, containing a total of 21,619 spots corresponding to 18,175 unique genes, followed by confocal laser scanning (Agilent Technologies).",Scanned on an Agilent G2565AA scanner.,Images were quantified using Agilent Feature Extraction Software (version A.7.5).,n/a,"LOWESS normalized, background subtracted VALUE data obtained from log10 of processed Red signal/processed Green signal. Agilent software was used.",GPL7015,"Takashi,,Takahashi",Aichi Cancer Center,"1-1 Kanokoden, Chikusa-ku",Nagoya,Aichi,464-8681,Japan,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM303nnn/GSM303023/suppl/GSM303023.txt.gz,21619,61,AD028,+,Wt,N,TRU-b,,Well,AD,Not obvious,Wt,Negative,Wt,69,78,IA,T1N0M0,M,,150,Alive,2873
GSM303024,Patient 029 with adenocarcinoma,GSM303024,Public on Apr 01 2009,Jul 02 2008,Jul 02 2008,RNA,2,Primary lung tumor,Homo sapiens,Annotation: AD029,Position in Figure 1 (L to R): 100,Age: 62,Sex: M,Histology: AD,Smoking (BI): 1600,pTNM: T2N1M0,pStage: IIB,Status: Alive,Survival (days): 2979,Evidence of relapse: N,Site of relapse:,EGFR status: Wt,K-ras Status: Wt,p53 Status: Mut,Gefitinib treatment:,Position in Figure 2 (L to R): 1,Expression profile-based classification: Non-TRU,Invasion: Definite,Necrosis: Negative,Grade: Poorly,BAC features: -,total RNA,"Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 250 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.",Cy5,"cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescent Linear Amplification kit (Agilent Technologies, Palo Alto, CA).",9606,"Total RNA from 20 lung cell lines representing all major histological types of lung cancers, labeled with Cyanine-3 (green).",Homo sapiens,n/a,total RNA,"Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 250 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.",Cy3,"cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescent Linear Amplification kit (Agilent Technologies, Palo Alto, CA).",9606,"Cy5-sample cRNA and Cy3-common reference cRNA were hybridized to a custom Agilent oligonucleotide microarray, containing a total of 21,619 spots corresponding to 18,175 unique genes, followed by confocal laser scanning (Agilent Technologies).",Scanned on an Agilent G2565AA scanner.,Images were quantified using Agilent Feature Extraction Software (version A.7.5).,n/a,"LOWESS normalized, background subtracted VALUE data obtained from log10 of processed Red signal/processed Green signal. Agilent software was used.",GPL7015,"Takashi,,Takahashi",Aichi Cancer Center,"1-1 Kanokoden, Chikusa-ku",Nagoya,Aichi,464-8681,Japan,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM303nnn/GSM303024/suppl/GSM303024.txt.gz,21619,62,AD029,-,Wt,N,Non-TRU,,Poorly,AD,Definite,Wt,Negative,Mut,100,1,IIB,T2N1M0,M,,1600,Alive,2979
GSM303025,Patient 030 with adenocarcinoma,GSM303025,Public on Apr 01 2009,Jul 02 2008,Jul 02 2008,RNA,2,Primary lung tumor,Homo sapiens,Annotation: AD030,Position in Figure 1 (L to R): 91,Age: 61,Sex: M,Histology: AD,Smoking (BI): 1140,pTNM: T2N0M0,pStage: IB,Status: Alive,Survival (days): 2905,Evidence of relapse: N,Site of relapse:,EGFR status: Wt,K-ras Status: Mut,p53 Status: Wt,Gefitinib treatment:,Position in Figure 2 (L to R): 66,Expression profile-based classification: TRU-a,Invasion: Definite,Necrosis: Positive,Grade: Poorly,BAC features: +,total RNA,"Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 250 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.",Cy5,"cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescent Linear Amplification kit (Agilent Technologies, Palo Alto, CA).",9606,"Total RNA from 20 lung cell lines representing all major histological types of lung cancers, labeled with Cyanine-3 (green).",Homo sapiens,n/a,total RNA,"Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 250 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.",Cy3,"cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescent Linear Amplification kit (Agilent Technologies, Palo Alto, CA).",9606,"Cy5-sample cRNA and Cy3-common reference cRNA were hybridized to a custom Agilent oligonucleotide microarray, containing a total of 21,619 spots corresponding to 18,175 unique genes, followed by confocal laser scanning (Agilent Technologies).",Scanned on an Agilent G2565AA scanner.,Images were quantified using Agilent Feature Extraction Software (version A.7.5).,n/a,"LOWESS normalized, background subtracted VALUE data obtained from log10 of processed Red signal/processed Green signal. Agilent software was used.",GPL7015,"Takashi,,Takahashi",Aichi Cancer Center,"1-1 Kanokoden, Chikusa-ku",Nagoya,Aichi,464-8681,Japan,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM303nnn/GSM303025/suppl/GSM303025.txt.gz,21619,61,AD030,+,Wt,N,TRU-a,,Poorly,AD,Definite,Mut,Positive,Wt,91,66,IB,T2N0M0,M,,1140,Alive,2905
GSM303026,Patient 031 with adenocarcinoma,GSM303026,Public on Apr 01 2009,Jul 02 2008,Jul 02 2008,RNA,2,Primary lung tumor,Homo sapiens,Annotation: AD031,Position in Figure 1 (L to R): 137,Age: 32,Sex: F,Histology: AD,Smoking (BI): 0,pTNM: T4N2M0,pStage: IIIB,Status: Dead,Survival (days): 2885,Evidence of relapse: Y,Site of relapse: PM,EGFR status: Wt,K-ras Status: Wt,p53 Status: Wt,Gefitinib treatment: Y,Position in Figure 2 (L to R): 75,Expression profile-based classification: TRU-b,Invasion: Not obvious,Necrosis: Negative,Grade: Well,BAC features: +,total RNA,"Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 250 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.",Cy5,"cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescent Linear Amplification kit (Agilent Technologies, Palo Alto, CA).",9606,"Total RNA from 20 lung cell lines representing all major histological types of lung cancers, labeled with Cyanine-3 (green).",Homo sapiens,n/a,total RNA,"Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 250 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.",Cy3,"cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescent Linear Amplification kit (Agilent Technologies, Palo Alto, CA).",9606,"Cy5-sample cRNA and Cy3-common reference cRNA were hybridized to a custom Agilent oligonucleotide microarray, containing a total of 21,619 spots corresponding to 18,175 unique genes, followed by confocal laser scanning (Agilent Technologies).",Scanned on an Agilent G2565AA scanner.,Images were quantified using Agilent Feature Extraction Software (version A.7.5).,n/a,"LOWESS normalized, background subtracted VALUE data obtained from log10 of processed Red signal/processed Green signal. Agilent software was used.",GPL7015,"Takashi,,Takahashi",Aichi Cancer Center,"1-1 Kanokoden, Chikusa-ku",Nagoya,Aichi,464-8681,Japan,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM303nnn/GSM303026/suppl/GSM303026.txt.gz,21619,32,AD031,+,Wt,Y,TRU-b,Y,Well,AD,Not obvious,Wt,Negative,Wt,137,75,IIIB,T4N2M0,F,PM,0,Dead,2885
GSM303027,Patient 032 with adenocarcinoma,GSM303027,Public on Apr 01 2009,Jul 02 2008,Jul 02 2008,RNA,2,Primary lung tumor,Homo sapiens,Annotation: AD032,Position in Figure 1 (L to R): 122,Age: 53,Sex: M,Histology: AD,Smoking (BI): 1980,pTNM: T1N0M0,pStage: IA,Status: Alive,Survival (days): 2701,Evidence of relapse: Y,Site of relapse: Bone,EGFR status: Wt,K-ras Status: Wt,p53 Status: Wt,Gefitinib treatment:,Position in Figure 2 (L to R): 2,Expression profile-based classification: Non-TRU,Invasion: Definite,Necrosis: Positive,Grade: Poorly,BAC features: -,total RNA,"Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 250 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.",Cy5,"cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescent Linear Amplification kit (Agilent Technologies, Palo Alto, CA).",9606,"Total RNA from 20 lung cell lines representing all major histological types of lung cancers, labeled with Cyanine-3 (green).",Homo sapiens,n/a,total RNA,"Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 250 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.",Cy3,"cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescent Linear Amplification kit (Agilent Technologies, Palo Alto, CA).",9606,"Cy5-sample cRNA and Cy3-common reference cRNA were hybridized to a custom Agilent oligonucleotide microarray, containing a total of 21,619 spots corresponding to 18,175 unique genes, followed by confocal laser scanning (Agilent Technologies).",Scanned on an Agilent G2565AA scanner.,Images were quantified using Agilent Feature Extraction Software (version A.7.5).,n/a,"LOWESS normalized, background subtracted VALUE data obtained from log10 of processed Red signal/processed Green signal. Agilent software was used.",GPL7015,"Takashi,,Takahashi",Aichi Cancer Center,"1-1 Kanokoden, Chikusa-ku",Nagoya,Aichi,464-8681,Japan,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM303nnn/GSM303027/suppl/GSM303027.txt.gz,21619,53,AD032,-,Wt,Y,Non-TRU,,Poorly,AD,Definite,Wt,Positive,Wt,122,2,IA,T1N0M0,M,Bone,1980,Alive,2701
GSM303028,Patient 033 with adenocarcinoma,GSM303028,Public on Apr 01 2009,Jul 02 2008,Jul 02 2008,RNA,2,Primary lung tumor,Homo sapiens,Annotation: AD033,Position in Figure 1 (L to R): 74,Age: 66,Sex: M,Histology: AD,Smoking (BI): 0,pTNM: T4N0M0,pStage: IIIB,Status: Dead,Survival (days): 896,Evidence of relapse: Y,Site of relapse: PM,EGFR status: Wt,K-ras Status: Mut,p53 Status: Wt,Gefitinib treatment:,Position in Figure 2 (L to R): 55,Expression profile-based classification: TRU-a,Invasion: Definite but focal,Necrosis: Negative,Grade: Well,BAC features: -,total RNA,"Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 250 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.",Cy5,"cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescent Linear Amplification kit (Agilent Technologies, Palo Alto, CA).",9606,"Total RNA from 20 lung cell lines representing all major histological types of lung cancers, labeled with Cyanine-3 (green).",Homo sapiens,n/a,total RNA,"Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 250 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.",Cy3,"cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescent Linear Amplification kit (Agilent Technologies, Palo Alto, CA).",9606,"Cy5-sample cRNA and Cy3-common reference cRNA were hybridized to a custom Agilent oligonucleotide microarray, containing a total of 21,619 spots corresponding to 18,175 unique genes, followed by confocal laser scanning (Agilent Technologies).",Scanned on an Agilent G2565AA scanner.,Images were quantified using Agilent Feature Extraction Software (version A.7.5).,n/a,"LOWESS normalized, background subtracted VALUE data obtained from log10 of processed Red signal/processed Green signal. Agilent software was used.",GPL7015,"Takashi,,Takahashi",Aichi Cancer Center,"1-1 Kanokoden, Chikusa-ku",Nagoya,Aichi,464-8681,Japan,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM303nnn/GSM303028/suppl/GSM303028.txt.gz,21619,66,AD033,-,Wt,Y,TRU-a,,Well,AD,Definite but focal,Mut,Negative,Wt,74,55,IIIB,T4N0M0,M,PM,0,Dead,896
GSM303029,Patient 034 with adenocarcinoma,GSM303029,Public on Apr 01 2009,Jul 02 2008,Jul 02 2008,RNA,2,Primary lung tumor,Homo sapiens,Annotation: AD034,Position in Figure 1 (L to R): 51,Age: 55,Sex: F,Histology: AD,Smoking (BI): 0,pTNM: T3N2M0,pStage: IIIA,Status: Alive,Survival (days): 2910,Evidence of relapse: Y,Site of relapse: LN (neck),EGFR status: Wt,K-ras Status: Wt,p53 Status: Mut,Gefitinib treatment:,Position in Figure 2 (L to R): 7,Expression profile-based classification: Non-TRU,Invasion: Definite,Necrosis: Positive,Grade: Poorly,BAC features: -,total RNA,"Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 250 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.",Cy5,"cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescent Linear Amplification kit (Agilent Technologies, Palo Alto, CA).",9606,"Total RNA from 20 lung cell lines representing all major histological types of lung cancers, labeled with Cyanine-3 (green).",Homo sapiens,n/a,total RNA,"Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 250 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.",Cy3,"cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescent Linear Amplification kit (Agilent Technologies, Palo Alto, CA).",9606,"Cy5-sample cRNA and Cy3-common reference cRNA were hybridized to a custom Agilent oligonucleotide microarray, containing a total of 21,619 spots corresponding to 18,175 unique genes, followed by confocal laser scanning (Agilent Technologies).",Scanned on an Agilent G2565AA scanner.,Images were quantified using Agilent Feature Extraction Software (version A.7.5).,n/a,"LOWESS normalized, background subtracted VALUE data obtained from log10 of processed Red signal/processed Green signal. Agilent software was used.",GPL7015,"Takashi,,Takahashi",Aichi Cancer Center,"1-1 Kanokoden, Chikusa-ku",Nagoya,Aichi,464-8681,Japan,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM303nnn/GSM303029/suppl/GSM303029.txt.gz,21619,55,AD034,-,Wt,Y,Non-TRU,,Poorly,AD,Definite,Wt,Positive,Mut,51,7,IIIA,T3N2M0,F,LN (neck),0,Alive,2910
GSM303030,Patient 035 with adenocarcinoma,GSM303030,Public on Apr 01 2009,Jul 02 2008,Jul 02 2008,RNA,2,Primary lung tumor,Homo sapiens,Annotation: AD035,Position in Figure 1 (L to R): 61,Age: 62,Sex: M,Histology: AD,Smoking (BI): 400,pTNM: T3N0M0,pStage: IIB,Status: Alive,Survival (days): 2813,Evidence of relapse: N,Site of relapse:,EGFR status: Wt,K-ras Status: Wt,p53 Status: Wt,Gefitinib treatment:,Position in Figure 2 (L to R): 70,Expression profile-based classification: TRU-a,Invasion: Definite,Necrosis: Negative,Grade: Well,BAC features: -,total RNA,"Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 250 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.",Cy5,"cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescent Linear Amplification kit (Agilent Technologies, Palo Alto, CA).",9606,"Total RNA from 20 lung cell lines representing all major histological types of lung cancers, labeled with Cyanine-3 (green).",Homo sapiens,n/a,total RNA,"Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 250 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.",Cy3,"cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescent Linear Amplification kit (Agilent Technologies, Palo Alto, CA).",9606,"Cy5-sample cRNA and Cy3-common reference cRNA were hybridized to a custom Agilent oligonucleotide microarray, containing a total of 21,619 spots corresponding to 18,175 unique genes, followed by confocal laser scanning (Agilent Technologies).",Scanned on an Agilent G2565AA scanner.,Images were quantified using Agilent Feature Extraction Software (version A.7.5).,n/a,"LOWESS normalized, background subtracted VALUE data obtained from log10 of processed Red signal/processed Green signal. Agilent software was used.",GPL7015,"Takashi,,Takahashi",Aichi Cancer Center,"1-1 Kanokoden, Chikusa-ku",Nagoya,Aichi,464-8681,Japan,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM303nnn/GSM303030/suppl/GSM303030.txt.gz,21619,62,AD035,-,Wt,N,TRU-a,,Well,AD,Definite,Wt,Negative,Wt,61,70,IIB,T3N0M0,M,,400,Alive,2813
GSM303031,Patient 036 with adenocarcinoma,GSM303031,Public on Apr 01 2009,Jul 02 2008,Jul 02 2008,RNA,2,Primary lung tumor,Homo sapiens,Annotation: AD036,Position in Figure 1 (L to R): 67,Age: 64,Sex: F,Histology: AD,Smoking (BI): 0,pTNM: T2N0M0,pStage: IB,Status: Alive,Survival (days): 2749,Evidence of relapse: N,Site of relapse:,EGFR status: Mut,K-ras Status: Wt,p53 Status: Wt,Gefitinib treatment:,Position in Figure 2 (L to R): 80,Expression profile-based classification: TRU-b,Invasion: Not obvious,Necrosis: Negative,Grade: Well,BAC features: +,total RNA,"Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 250 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.",Cy5,"cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescent Linear Amplification kit (Agilent Technologies, Palo Alto, CA).",9606,"Total RNA from 20 lung cell lines representing all major histological types of lung cancers, labeled with Cyanine-3 (green).",Homo sapiens,n/a,total RNA,"Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 250 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.",Cy3,"cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescent Linear Amplification kit (Agilent Technologies, Palo Alto, CA).",9606,"Cy5-sample cRNA and Cy3-common reference cRNA were hybridized to a custom Agilent oligonucleotide microarray, containing a total of 21,619 spots corresponding to 18,175 unique genes, followed by confocal laser scanning (Agilent Technologies).",Scanned on an Agilent G2565AA scanner.,Images were quantified using Agilent Feature Extraction Software (version A.7.5).,n/a,"LOWESS normalized, background subtracted VALUE data obtained from log10 of processed Red signal/processed Green signal. Agilent software was used.",GPL7015,"Takashi,,Takahashi",Aichi Cancer Center,"1-1 Kanokoden, Chikusa-ku",Nagoya,Aichi,464-8681,Japan,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM303nnn/GSM303031/suppl/GSM303031.txt.gz,21619,64,AD036,+,Mut,N,TRU-b,,Well,AD,Not obvious,Wt,Negative,Wt,67,80,IB,T2N0M0,F,,0,Alive,2749
GSM303032,Patient 037 with adenocarcinoma,GSM303032,Public on Apr 01 2009,Jul 02 2008,Jul 02 2008,RNA,2,Primary lung tumor,Homo sapiens,Annotation: AD037,Position in Figure 1 (L to R): 94,Age: 63,Sex: F,Histology: AD,Smoking (BI): 0,pTNM: T1N0M0,pStage: IA,Status: Alive,Survival (days): 2932,Evidence of relapse: Y,Site of relapse: PM,EGFR status: Mut,K-ras Status: Wt,p53 Status: Wt,Gefitinib treatment: Y,Position in Figure 2 (L to R): 41,Expression profile-based classification: TRU-a,Invasion: Definite but focal,Necrosis: Negative,Grade: Well,BAC features: -,total RNA,"Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 250 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.",Cy5,"cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescent Linear Amplification kit (Agilent Technologies, Palo Alto, CA).",9606,"Total RNA from 20 lung cell lines representing all major histological types of lung cancers, labeled with Cyanine-3 (green).",Homo sapiens,n/a,total RNA,"Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 250 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.",Cy3,"cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescent Linear Amplification kit (Agilent Technologies, Palo Alto, CA).",9606,"Cy5-sample cRNA and Cy3-common reference cRNA were hybridized to a custom Agilent oligonucleotide microarray, containing a total of 21,619 spots corresponding to 18,175 unique genes, followed by confocal laser scanning (Agilent Technologies).",Scanned on an Agilent G2565AA scanner.,Images were quantified using Agilent Feature Extraction Software (version A.7.5).,n/a,"LOWESS normalized, background subtracted VALUE data obtained from log10 of processed Red signal/processed Green signal. Agilent software was used.",GPL7015,"Takashi,,Takahashi",Aichi Cancer Center,"1-1 Kanokoden, Chikusa-ku",Nagoya,Aichi,464-8681,Japan,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM303nnn/GSM303032/suppl/GSM303032.txt.gz,21619,63,AD037,-,Mut,Y,TRU-a,Y,Well,AD,Definite but focal,Wt,Negative,Wt,94,41,IA,T1N0M0,F,PM,0,Alive,2932
GSM303033,Patient 038 with adenocarcinoma,GSM303033,Public on Apr 01 2009,Jul 02 2008,Jul 02 2008,RNA,2,Primary lung tumor,Homo sapiens,Annotation: AD038,Position in Figure 1 (L to R): 83,Age: 69,Sex: F,Histology: AD,Smoking (BI): 0,pTNM: T2N0M0,pStage: IB,Status: Dead,Survival (days): 1389,Evidence of relapse: Y,Site of relapse: Local rec.,EGFR status: Mut,K-ras Status: Wt,p53 Status: Wt,Gefitinib treatment:,Position in Figure 2 (L to R): 46,Expression profile-based classification: TRU-a,Invasion: Definite,Necrosis: Negative,Grade: Moderately,BAC features: -,total RNA,"Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 250 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.",Cy5,"cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescent Linear Amplification kit (Agilent Technologies, Palo Alto, CA).",9606,"Total RNA from 20 lung cell lines representing all major histological types of lung cancers, labeled with Cyanine-3 (green).",Homo sapiens,n/a,total RNA,"Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 250 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.",Cy3,"cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescent Linear Amplification kit (Agilent Technologies, Palo Alto, CA).",9606,"Cy5-sample cRNA and Cy3-common reference cRNA were hybridized to a custom Agilent oligonucleotide microarray, containing a total of 21,619 spots corresponding to 18,175 unique genes, followed by confocal laser scanning (Agilent Technologies).",Scanned on an Agilent G2565AA scanner.,Images were quantified using Agilent Feature Extraction Software (version A.7.5).,n/a,"LOWESS normalized, background subtracted VALUE data obtained from log10 of processed Red signal/processed Green signal. Agilent software was used.",GPL7015,"Takashi,,Takahashi",Aichi Cancer Center,"1-1 Kanokoden, Chikusa-ku",Nagoya,Aichi,464-8681,Japan,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM303nnn/GSM303033/suppl/GSM303033.txt.gz,21619,69,AD038,-,Mut,Y,TRU-a,,Moderately,AD,Definite,Wt,Negative,Wt,83,46,IB,T2N0M0,F,Local rec.,0,Dead,1389
GSM303034,Patient 039 with adenocarcinoma,GSM303034,Public on Apr 01 2009,Jul 02 2008,Jul 02 2008,RNA,2,Primary lung tumor,Homo sapiens,Annotation: AD039,Position in Figure 1 (L to R): 76,Age: 52,Sex: F,Histology: AD,Smoking (BI): 0,pTNM: T2N0M0,pStage: IB,Status: Alive,Survival (days): 2796,Evidence of relapse: N,Site of relapse:,EGFR status: Mut,K-ras Status: Wt,p53 Status: Wt,Gefitinib treatment:,Position in Figure 2 (L to R): 51,Expression profile-based classification: TRU-a,Invasion: Definite,Necrosis: Negative,Grade: Well,BAC features: +,total RNA,"Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 250 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.",Cy5,"cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescent Linear Amplification kit (Agilent Technologies, Palo Alto, CA).",9606,"Total RNA from 20 lung cell lines representing all major histological types of lung cancers, labeled with Cyanine-3 (green).",Homo sapiens,n/a,total RNA,"Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 250 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.",Cy3,"cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescent Linear Amplification kit (Agilent Technologies, Palo Alto, CA).",9606,"Cy5-sample cRNA and Cy3-common reference cRNA were hybridized to a custom Agilent oligonucleotide microarray, containing a total of 21,619 spots corresponding to 18,175 unique genes, followed by confocal laser scanning (Agilent Technologies).",Scanned on an Agilent G2565AA scanner.,Images were quantified using Agilent Feature Extraction Software (version A.7.5).,n/a,"LOWESS normalized, background subtracted VALUE data obtained from log10 of processed Red signal/processed Green signal. Agilent software was used.",GPL7015,"Takashi,,Takahashi",Aichi Cancer Center,"1-1 Kanokoden, Chikusa-ku",Nagoya,Aichi,464-8681,Japan,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM303nnn/GSM303034/suppl/GSM303034.txt.gz,21619,52,AD039,+,Mut,N,TRU-a,,Well,AD,Definite,Wt,Negative,Wt,76,51,IB,T2N0M0,F,,0,Alive,2796
GSM303035,Patient 040 with adenocarcinoma,GSM303035,Public on Apr 01 2009,Jul 02 2008,Jul 02 2008,RNA,2,Primary lung tumor,Homo sapiens,Annotation: AD040,Position in Figure 1 (L to R): 82,Age: 52,Sex: F,Histology: AD,Smoking (BI): 0,pTNM: T2N2M0,pStage: IIIA,Status: Dead,Survival (days): 361,Evidence of relapse: Y,Site of relapse: Bone,EGFR status: Mut,K-ras Status: Wt,p53 Status: Wt,Gefitinib treatment:,Position in Figure 2 (L to R): 45,Expression profile-based classification: TRU-a,Invasion: Definite,Necrosis: Negative,Grade: Poorly,BAC features: -,total RNA,"Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 250 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.",Cy5,"cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescent Linear Amplification kit (Agilent Technologies, Palo Alto, CA).",9606,"Total RNA from 20 lung cell lines representing all major histological types of lung cancers, labeled with Cyanine-3 (green).",Homo sapiens,n/a,total RNA,"Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 250 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.",Cy3,"cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescent Linear Amplification kit (Agilent Technologies, Palo Alto, CA).",9606,"Cy5-sample cRNA and Cy3-common reference cRNA were hybridized to a custom Agilent oligonucleotide microarray, containing a total of 21,619 spots corresponding to 18,175 unique genes, followed by confocal laser scanning (Agilent Technologies).",Scanned on an Agilent G2565AA scanner.,Images were quantified using Agilent Feature Extraction Software (version A.7.5).,n/a,"LOWESS normalized, background subtracted VALUE data obtained from log10 of processed Red signal/processed Green signal. Agilent software was used.",GPL7015,"Takashi,,Takahashi",Aichi Cancer Center,"1-1 Kanokoden, Chikusa-ku",Nagoya,Aichi,464-8681,Japan,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM303nnn/GSM303035/suppl/GSM303035.txt.gz,21619,52,AD040,-,Mut,Y,TRU-a,,Poorly,AD,Definite,Wt,Negative,Wt,82,45,IIIA,T2N2M0,F,Bone,0,Dead,361
GSM303036,Patient 041 with adenocarcinoma,GSM303036,Public on Apr 01 2009,Jul 02 2008,Jul 02 2008,RNA,2,Primary lung tumor,Homo sapiens,Annotation: AD041,Position in Figure 1 (L to R): 58,Age: 62,Sex: M,Histology: AD,Smoking (BI): 0,pTNM: T2N2M0,pStage: IIIA,Status: Dead,Survival (days): 397,Evidence of relapse: Y,Site of relapse: PM,EGFR status: Mut,K-ras Status: Wt,p53 Status: Mut,Gefitinib treatment:,Position in Figure 2 (L to R): 42,Expression profile-based classification: TRU-a,Invasion: Definite,Necrosis: Negative,Grade: Moderately,BAC features: -,total RNA,"Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 250 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.",Cy5,"cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescent Linear Amplification kit (Agilent Technologies, Palo Alto, CA).",9606,"Total RNA from 20 lung cell lines representing all major histological types of lung cancers, labeled with Cyanine-3 (green).",Homo sapiens,n/a,total RNA,"Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 250 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.",Cy3,"cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescent Linear Amplification kit (Agilent Technologies, Palo Alto, CA).",9606,"Cy5-sample cRNA and Cy3-common reference cRNA were hybridized to a custom Agilent oligonucleotide microarray, containing a total of 21,619 spots corresponding to 18,175 unique genes, followed by confocal laser scanning (Agilent Technologies).",Scanned on an Agilent G2565AA scanner.,Images were quantified using Agilent Feature Extraction Software (version A.7.5).,n/a,"LOWESS normalized, background subtracted VALUE data obtained from log10 of processed Red signal/processed Green signal. Agilent software was used.",GPL7015,"Takashi,,Takahashi",Aichi Cancer Center,"1-1 Kanokoden, Chikusa-ku",Nagoya,Aichi,464-8681,Japan,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM303nnn/GSM303036/suppl/GSM303036.txt.gz,21619,62,AD041,-,Mut,Y,TRU-a,,Moderately,AD,Definite,Wt,Negative,Mut,58,42,IIIA,T2N2M0,M,PM,0,Dead,397
GSM303037,Patient 042 with adenocarcinoma,GSM303037,Public on Apr 01 2009,Jul 02 2008,Jul 02 2008,RNA,2,Primary lung tumor,Homo sapiens,Annotation: AD042,Position in Figure 1 (L to R): 81,Age: 62,Sex: M,Histology: AD,Smoking (BI): 840,pTNM: T1N0M0,pStage: IA,Status: Alive,Survival (days): 2506,Evidence of relapse: N,Site of relapse:,EGFR status: Wt,K-ras Status: Wt,p53 Status: Wt,Gefitinib treatment:,Position in Figure 2 (L to R): 48,Expression profile-based classification: TRU-a,Invasion: Definite but focal,Necrosis: Negative,Grade: Well,BAC features: +,total RNA,"Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 250 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.",Cy5,"cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescent Linear Amplification kit (Agilent Technologies, Palo Alto, CA).",9606,"Total RNA from 20 lung cell lines representing all major histological types of lung cancers, labeled with Cyanine-3 (green).",Homo sapiens,n/a,total RNA,"Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 250 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.",Cy3,"cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescent Linear Amplification kit (Agilent Technologies, Palo Alto, CA).",9606,"Cy5-sample cRNA and Cy3-common reference cRNA were hybridized to a custom Agilent oligonucleotide microarray, containing a total of 21,619 spots corresponding to 18,175 unique genes, followed by confocal laser scanning (Agilent Technologies).",Scanned on an Agilent G2565AA scanner.,Images were quantified using Agilent Feature Extraction Software (version A.7.5).,n/a,"LOWESS normalized, background subtracted VALUE data obtained from log10 of processed Red signal/processed Green signal. Agilent software was used.",GPL7015,"Takashi,,Takahashi",Aichi Cancer Center,"1-1 Kanokoden, Chikusa-ku",Nagoya,Aichi,464-8681,Japan,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM303nnn/GSM303037/suppl/GSM303037.txt.gz,21619,62,AD042,+,Wt,N,TRU-a,,Well,AD,Definite but focal,Wt,Negative,Wt,81,48,IA,T1N0M0,M,,840,Alive,2506
GSM303038,Patient 043 with adenocarcinoma,GSM303038,Public on Apr 01 2009,Jul 02 2008,Jul 02 2008,RNA,2,Primary lung tumor,Homo sapiens,Annotation: AD043,Position in Figure 1 (L to R): 98,Age: 67,Sex: M,Histology: AD,Smoking (BI): 820,pTNM: T2N0M0,pStage: IB,Status: Alive,Survival (days): 2426,Evidence of relapse: N,Site of relapse:,EGFR status: Wt,K-ras Status: Wt,p53 Status: Wt,Gefitinib treatment:,Position in Figure 2 (L to R): 11,Expression profile-based classification: Non-TRU,Invasion: Definite,Necrosis: Positive,Grade: Poorly,BAC features: -,total RNA,"Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 250 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.",Cy5,"cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescent Linear Amplification kit (Agilent Technologies, Palo Alto, CA).",9606,"Total RNA from 20 lung cell lines representing all major histological types of lung cancers, labeled with Cyanine-3 (green).",Homo sapiens,n/a,total RNA,"Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 250 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.",Cy3,"cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescent Linear Amplification kit (Agilent Technologies, Palo Alto, CA).",9606,"Cy5-sample cRNA and Cy3-common reference cRNA were hybridized to a custom Agilent oligonucleotide microarray, containing a total of 21,619 spots corresponding to 18,175 unique genes, followed by confocal laser scanning (Agilent Technologies).",Scanned on an Agilent G2565AA scanner.,Images were quantified using Agilent Feature Extraction Software (version A.7.5).,n/a,"LOWESS normalized, background subtracted VALUE data obtained from log10 of processed Red signal/processed Green signal. Agilent software was used.",GPL7015,"Takashi,,Takahashi",Aichi Cancer Center,"1-1 Kanokoden, Chikusa-ku",Nagoya,Aichi,464-8681,Japan,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM303nnn/GSM303038/suppl/GSM303038.txt.gz,21619,67,AD043,-,Wt,N,Non-TRU,,Poorly,AD,Definite,Wt,Positive,Wt,98,11,IB,T2N0M0,M,,820,Alive,2426
GSM303039,Patient 044 with adenocarcinoma,GSM303039,Public on Apr 01 2009,Jul 02 2008,Jul 02 2008,RNA,2,Primary lung tumor,Homo sapiens,Annotation: AD044,Position in Figure 1 (L to R): 106,Age: 63,Sex: F,Histology: AD,Smoking (BI): 0,pTNM: T1N2M0,pStage: IIIA,Status: Dead,Survival (days): 2193,Evidence of relapse: Y,Site of relapse: PM,EGFR status: Wt,K-ras Status: Wt,p53 Status: Wt,Gefitinib treatment: Y,Position in Figure 2 (L to R): 72,Expression profile-based classification: TRU-b,Invasion: Definite,Necrosis: Negative,Grade: Poorly,BAC features: -,total RNA,"Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 250 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.",Cy5,"cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescent Linear Amplification kit (Agilent Technologies, Palo Alto, CA).",9606,"Total RNA from 20 lung cell lines representing all major histological types of lung cancers, labeled with Cyanine-3 (green).",Homo sapiens,n/a,total RNA,"Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 250 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.",Cy3,"cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescent Linear Amplification kit (Agilent Technologies, Palo Alto, CA).",9606,"Cy5-sample cRNA and Cy3-common reference cRNA were hybridized to a custom Agilent oligonucleotide microarray, containing a total of 21,619 spots corresponding to 18,175 unique genes, followed by confocal laser scanning (Agilent Technologies).",Scanned on an Agilent G2565AA scanner.,Images were quantified using Agilent Feature Extraction Software (version A.7.5).,n/a,"LOWESS normalized, background subtracted VALUE data obtained from log10 of processed Red signal/processed Green signal. Agilent software was used.",GPL7015,"Takashi,,Takahashi",Aichi Cancer Center,"1-1 Kanokoden, Chikusa-ku",Nagoya,Aichi,464-8681,Japan,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM303nnn/GSM303039/suppl/GSM303039.txt.gz,21619,63,AD044,-,Wt,Y,TRU-b,Y,Poorly,AD,Definite,Wt,Negative,Wt,106,72,IIIA,T1N2M0,F,PM,0,Dead,2193
GSM303040,Patient 045 with adenocarcinoma,GSM303040,Public on Apr 01 2009,Jul 02 2008,Jul 02 2008,RNA,2,Primary lung tumor,Homo sapiens,Annotation: AD045,Position in Figure 1 (L to R): 104,Age: 49,Sex: F,Histology: AD,Smoking (BI): 0,pTNM: T2N0M0,pStage: IB,Status: Alive,Survival (days): 2797,Evidence of relapse: Y,Site of relapse: Adrenal,EGFR status: Mut,K-ras Status: Wt,p53 Status: Wt,Gefitinib treatment:,Position in Figure 2 (L to R): 37,Expression profile-based classification: Non-TRU,Invasion: Definite,Necrosis: Negative,Grade: Poorly,BAC features: -,total RNA,"Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 250 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.",Cy5,"cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescent Linear Amplification kit (Agilent Technologies, Palo Alto, CA).",9606,"Total RNA from 20 lung cell lines representing all major histological types of lung cancers, labeled with Cyanine-3 (green).",Homo sapiens,n/a,total RNA,"Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 250 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.",Cy3,"cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescent Linear Amplification kit (Agilent Technologies, Palo Alto, CA).",9606,"Cy5-sample cRNA and Cy3-common reference cRNA were hybridized to a custom Agilent oligonucleotide microarray, containing a total of 21,619 spots corresponding to 18,175 unique genes, followed by confocal laser scanning (Agilent Technologies).",Scanned on an Agilent G2565AA scanner.,Images were quantified using Agilent Feature Extraction Software (version A.7.5).,n/a,"LOWESS normalized, background subtracted VALUE data obtained from log10 of processed Red signal/processed Green signal. Agilent software was used.",GPL7015,"Takashi,,Takahashi",Aichi Cancer Center,"1-1 Kanokoden, Chikusa-ku",Nagoya,Aichi,464-8681,Japan,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM303nnn/GSM303040/suppl/GSM303040.txt.gz,21619,49,AD045,-,Mut,Y,Non-TRU,,Poorly,AD,Definite,Wt,Negative,Wt,104,37,IB,T2N0M0,F,Adrenal,0,Alive,2797
GSM303041,Patient 046 with adenocarcinoma,GSM303041,Public on Apr 01 2009,Jul 02 2008,Jul 02 2008,RNA,2,Primary lung tumor,Homo sapiens,Annotation: AD046,Position in Figure 1 (L to R): 138,Age: 59,Sex: F,Histology: AD,Smoking (BI): 0,pTNM: T2N1M0,pStage: IIB,Status: Alive,Survival (days): 2355,Evidence of relapse: Y,Site of relapse: Bone,EGFR status: Mut,K-ras Status: Wt,p53 Status: Wt,Gefitinib treatment:,Position in Figure 2 (L to R): 84,Expression profile-based classification: TRU-b,Invasion: Definite,Necrosis: Negative,Grade: Moderately,BAC features: -,total RNA,"Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 250 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.",Cy5,"cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescent Linear Amplification kit (Agilent Technologies, Palo Alto, CA).",9606,"Total RNA from 20 lung cell lines representing all major histological types of lung cancers, labeled with Cyanine-3 (green).",Homo sapiens,n/a,total RNA,"Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 250 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.",Cy3,"cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescent Linear Amplification kit (Agilent Technologies, Palo Alto, CA).",9606,"Cy5-sample cRNA and Cy3-common reference cRNA were hybridized to a custom Agilent oligonucleotide microarray, containing a total of 21,619 spots corresponding to 18,175 unique genes, followed by confocal laser scanning (Agilent Technologies).",Scanned on an Agilent G2565AA scanner.,Images were quantified using Agilent Feature Extraction Software (version A.7.5).,n/a,"LOWESS normalized, background subtracted VALUE data obtained from log10 of processed Red signal/processed Green signal. Agilent software was used.",GPL7015,"Takashi,,Takahashi",Aichi Cancer Center,"1-1 Kanokoden, Chikusa-ku",Nagoya,Aichi,464-8681,Japan,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM303nnn/GSM303041/suppl/GSM303041.txt.gz,21619,59,AD046,-,Mut,Y,TRU-b,,Moderately,AD,Definite,Wt,Negative,Wt,138,84,IIB,T2N1M0,F,Bone,0,Alive,2355
GSM303042,Patient 047 with adenocarcinoma,GSM303042,Public on Apr 01 2009,Jul 02 2008,Jul 02 2008,RNA,2,Primary lung tumor,Homo sapiens,Annotation: AD047,Position in Figure 1 (L to R): 140,Age: 46,Sex: M,Histology: AD,Smoking (BI): 0,pTNM: T1N1M0,pStage: IIA,Status: Alive,Survival (days): 2729,Evidence of relapse: N,Site of relapse:,EGFR status: Mut,K-ras Status: Wt,p53 Status: Mut,Gefitinib treatment:,Position in Figure 2 (L to R): 82,Expression profile-based classification: TRU-b,Invasion: Not obvious,Necrosis: Negative,Grade: Well,BAC features: +,total RNA,"Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 250 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.",Cy5,"cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescent Linear Amplification kit (Agilent Technologies, Palo Alto, CA).",9606,"Total RNA from 20 lung cell lines representing all major histological types of lung cancers, labeled with Cyanine-3 (green).",Homo sapiens,n/a,total RNA,"Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 250 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.",Cy3,"cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescent Linear Amplification kit (Agilent Technologies, Palo Alto, CA).",9606,"Cy5-sample cRNA and Cy3-common reference cRNA were hybridized to a custom Agilent oligonucleotide microarray, containing a total of 21,619 spots corresponding to 18,175 unique genes, followed by confocal laser scanning (Agilent Technologies).",Scanned on an Agilent G2565AA scanner.,Images were quantified using Agilent Feature Extraction Software (version A.7.5).,n/a,"LOWESS normalized, background subtracted VALUE data obtained from log10 of processed Red signal/processed Green signal. Agilent software was used.",GPL7015,"Takashi,,Takahashi",Aichi Cancer Center,"1-1 Kanokoden, Chikusa-ku",Nagoya,Aichi,464-8681,Japan,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM303nnn/GSM303042/suppl/GSM303042.txt.gz,21619,46,AD047,+,Mut,N,TRU-b,,Well,AD,Not obvious,Wt,Negative,Mut,140,82,IIA,T1N1M0,M,,0,Alive,2729
GSM303043,Patient 048 with adenocarcinoma,GSM303043,Public on Apr 01 2009,Jul 02 2008,Jul 02 2008,RNA,2,Primary lung tumor,Homo sapiens,Annotation: AD048,Position in Figure 1 (L to R): 139,Age: 61,Sex: F,Histology: AD,Smoking (BI): 0,pTNM: T1N0M0,pStage: IA,Status: Alive,Survival (days): 2702,Evidence of relapse: N,Site of relapse:,EGFR status: Mut,K-ras Status: Wt,p53 Status: Mut,Gefitinib treatment:,Position in Figure 2 (L to R): 83,Expression profile-based classification: TRU-b,Invasion: Definite but focal,Necrosis: Negative,Grade: Moderately,BAC features: -,total RNA,"Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 250 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.",Cy5,"cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescent Linear Amplification kit (Agilent Technologies, Palo Alto, CA).",9606,"Total RNA from 20 lung cell lines representing all major histological types of lung cancers, labeled with Cyanine-3 (green).",Homo sapiens,n/a,total RNA,"Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 250 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.",Cy3,"cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescent Linear Amplification kit (Agilent Technologies, Palo Alto, CA).",9606,"Cy5-sample cRNA and Cy3-common reference cRNA were hybridized to a custom Agilent oligonucleotide microarray, containing a total of 21,619 spots corresponding to 18,175 unique genes, followed by confocal laser scanning (Agilent Technologies).",Scanned on an Agilent G2565AA scanner.,Images were quantified using Agilent Feature Extraction Software (version A.7.5).,n/a,"LOWESS normalized, background subtracted VALUE data obtained from log10 of processed Red signal/processed Green signal. Agilent software was used.",GPL7015,"Takashi,,Takahashi",Aichi Cancer Center,"1-1 Kanokoden, Chikusa-ku",Nagoya,Aichi,464-8681,Japan,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM303nnn/GSM303043/suppl/GSM303043.txt.gz,21619,61,AD048,-,Mut,N,TRU-b,,Moderately,AD,Definite but focal,Wt,Negative,Mut,139,83,IA,T1N0M0,F,,0,Alive,2702
GSM303044,Patient 049 with adenocarcinoma,GSM303044,Public on Apr 01 2009,Jul 02 2008,Jul 02 2008,RNA,2,Primary lung tumor,Homo sapiens,Annotation: AD049,Position in Figure 1 (L to R): 103,Age: 35,Sex: F,Histology: AD,Smoking (BI): 20,pTNM: T4N2M0,pStage: IIIB,Status: Dead,Survival (days): 636,Evidence of relapse: Y,Site of relapse: Brain,EGFR status: Wt,K-ras Status: Wt,p53 Status: Wt,Gefitinib treatment:,Position in Figure 2 (L to R): 36,Expression profile-based classification: Non-TRU,Invasion: Definite,Necrosis: Positive,Grade: Poorly,BAC features: -,total RNA,"Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 250 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.",Cy5,"cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescent Linear Amplification kit (Agilent Technologies, Palo Alto, CA).",9606,"Total RNA from 20 lung cell lines representing all major histological types of lung cancers, labeled with Cyanine-3 (green).",Homo sapiens,n/a,total RNA,"Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 250 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.",Cy3,"cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescent Linear Amplification kit (Agilent Technologies, Palo Alto, CA).",9606,"Cy5-sample cRNA and Cy3-common reference cRNA were hybridized to a custom Agilent oligonucleotide microarray, containing a total of 21,619 spots corresponding to 18,175 unique genes, followed by confocal laser scanning (Agilent Technologies).",Scanned on an Agilent G2565AA scanner.,Images were quantified using Agilent Feature Extraction Software (version A.7.5).,n/a,"LOWESS normalized, background subtracted VALUE data obtained from log10 of processed Red signal/processed Green signal. Agilent software was used.",GPL7015,"Takashi,,Takahashi",Aichi Cancer Center,"1-1 Kanokoden, Chikusa-ku",Nagoya,Aichi,464-8681,Japan,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM303nnn/GSM303044/suppl/GSM303044.txt.gz,21619,35,AD049,-,Wt,Y,Non-TRU,,Poorly,AD,Definite,Wt,Positive,Wt,103,36,IIIB,T4N2M0,F,Brain,20,Dead,636
GSM303045,Patient 050 with adenocarcinoma,GSM303045,Public on Apr 01 2009,Jul 02 2008,Jul 02 2008,RNA,2,Primary lung tumor,Homo sapiens,Annotation: AD050,Position in Figure 1 (L to R): 112,Age: 76,Sex: M,Histology: AD,Smoking (BI): 1620,pTNM: T2N0M0,pStage: IB,Status: Dead,Survival (days): 828,Evidence of relapse: Unknown,Site of relapse:,EGFR status: Wt,K-ras Status: Mut,p53 Status: Wt,Gefitinib treatment:,Position in Figure 2 (L to R): 20,Expression profile-based classification: Non-TRU,Invasion: Definite but focal,Necrosis: Negative,Grade: Well,BAC features: +,total RNA,"Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 250 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.",Cy5,"cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescent Linear Amplification kit (Agilent Technologies, Palo Alto, CA).",9606,"Total RNA from 20 lung cell lines representing all major histological types of lung cancers, labeled with Cyanine-3 (green).",Homo sapiens,n/a,total RNA,"Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 250 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.",Cy3,"cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescent Linear Amplification kit (Agilent Technologies, Palo Alto, CA).",9606,"Cy5-sample cRNA and Cy3-common reference cRNA were hybridized to a custom Agilent oligonucleotide microarray, containing a total of 21,619 spots corresponding to 18,175 unique genes, followed by confocal laser scanning (Agilent Technologies).",Scanned on an Agilent G2565AA scanner.,Images were quantified using Agilent Feature Extraction Software (version A.7.5).,n/a,"LOWESS normalized, background subtracted VALUE data obtained from log10 of processed Red signal/processed Green signal. Agilent software was used.",GPL7015,"Takashi,,Takahashi",Aichi Cancer Center,"1-1 Kanokoden, Chikusa-ku",Nagoya,Aichi,464-8681,Japan,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM303nnn/GSM303045/suppl/GSM303045.txt.gz,21619,76,AD050,+,Wt,Unknown,Non-TRU,,Well,AD,Definite but focal,Mut,Negative,Wt,112,20,IB,T2N0M0,M,,1620,Dead,828
GSM303046,Patient 051 with adenocarcinoma,GSM303046,Public on Apr 01 2009,Jul 02 2008,Jul 02 2008,RNA,2,Primary lung tumor,Homo sapiens,Annotation: AD051,Position in Figure 1 (L to R): 89,Age: 76,Sex: F,Histology: AD,Smoking (BI): 0,pTNM: T2N0M0,pStage: IB,Status: Alive,Survival (days): 2702,Evidence of relapse: N,Site of relapse:,EGFR status: Wt,K-ras Status: Wt,p53 Status: Mut,Gefitinib treatment:,Position in Figure 2 (L to R): 60,Expression profile-based classification: TRU-a,Invasion: Definite,Necrosis: Positive,Grade: Poorly,BAC features: -,total RNA,"Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 250 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.",Cy5,"cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescent Linear Amplification kit (Agilent Technologies, Palo Alto, CA).",9606,"Total RNA from 20 lung cell lines representing all major histological types of lung cancers, labeled with Cyanine-3 (green).",Homo sapiens,n/a,total RNA,"Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 250 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.",Cy3,"cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescent Linear Amplification kit (Agilent Technologies, Palo Alto, CA).",9606,"Cy5-sample cRNA and Cy3-common reference cRNA were hybridized to a custom Agilent oligonucleotide microarray, containing a total of 21,619 spots corresponding to 18,175 unique genes, followed by confocal laser scanning (Agilent Technologies).",Scanned on an Agilent G2565AA scanner.,Images were quantified using Agilent Feature Extraction Software (version A.7.5).,n/a,"LOWESS normalized, background subtracted VALUE data obtained from log10 of processed Red signal/processed Green signal. Agilent software was used.",GPL7015,"Takashi,,Takahashi",Aichi Cancer Center,"1-1 Kanokoden, Chikusa-ku",Nagoya,Aichi,464-8681,Japan,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM303nnn/GSM303046/suppl/GSM303046.txt.gz,21619,76,AD051,-,Wt,N,TRU-a,,Poorly,AD,Definite,Wt,Positive,Mut,89,60,IB,T2N0M0,F,,0,Alive,2702
GSM303047,Patient 052 with adenocarcinoma,GSM303047,Public on Apr 01 2009,Jul 02 2008,Jul 02 2008,RNA,2,Primary lung tumor,Homo sapiens,Annotation: AD052,Position in Figure 1 (L to R): 131,Age: 84,Sex: F,Histology: AD,Smoking (BI): 0,pTNM: T2N0M0,pStage: IB,Status: Alive,Survival (days): 2456,Evidence of relapse: N,Site of relapse:,EGFR status: Wt,K-ras Status: Wt,p53 Status: Wt,Gefitinib treatment:,Position in Figure 2 (L to R): 6,Expression profile-based classification: Non-TRU,Invasion: Definite,Necrosis: Positive,Grade: Poorly,BAC features: -,total RNA,"Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 250 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.",Cy5,"cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescent Linear Amplification kit (Agilent Technologies, Palo Alto, CA).",9606,"Total RNA from 20 lung cell lines representing all major histological types of lung cancers, labeled with Cyanine-3 (green).",Homo sapiens,n/a,total RNA,"Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 250 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.",Cy3,"cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescent Linear Amplification kit (Agilent Technologies, Palo Alto, CA).",9606,"Cy5-sample cRNA and Cy3-common reference cRNA were hybridized to a custom Agilent oligonucleotide microarray, containing a total of 21,619 spots corresponding to 18,175 unique genes, followed by confocal laser scanning (Agilent Technologies).",Scanned on an Agilent G2565AA scanner.,Images were quantified using Agilent Feature Extraction Software (version A.7.5).,n/a,"LOWESS normalized, background subtracted VALUE data obtained from log10 of processed Red signal/processed Green signal. Agilent software was used.",GPL7015,"Takashi,,Takahashi",Aichi Cancer Center,"1-1 Kanokoden, Chikusa-ku",Nagoya,Aichi,464-8681,Japan,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM303nnn/GSM303047/suppl/GSM303047.txt.gz,21619,84,AD052,-,Wt,N,Non-TRU,,Poorly,AD,Definite,Wt,Positive,Wt,131,6,IB,T2N0M0,F,,0,Alive,2456
GSM303048,Patient 053 with adenocarcinoma,GSM303048,Public on Apr 01 2009,Jul 02 2008,Jul 02 2008,RNA,2,Primary lung tumor,Homo sapiens,Annotation: AD053,Position in Figure 1 (L to R): 114,Age: 64,Sex: M,Histology: AD,Smoking (BI): 1540,pTNM: T2N2M0,pStage: IIIA,Status: Dead,Survival (days): 784,Evidence of relapse: Y,Site of relapse: LN (neck),EGFR status: Wt,K-ras Status: Mut,p53 Status: Mut,Gefitinib treatment:,Position in Figure 2 (L to R): 19,Expression profile-based classification: Non-TRU,Invasion: Definite,Necrosis: Positive,Grade: Moderately,BAC features: -,total RNA,"Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 250 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.",Cy5,"cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescent Linear Amplification kit (Agilent Technologies, Palo Alto, CA).",9606,"Total RNA from 20 lung cell lines representing all major histological types of lung cancers, labeled with Cyanine-3 (green).",Homo sapiens,n/a,total RNA,"Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 250 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.",Cy3,"cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescent Linear Amplification kit (Agilent Technologies, Palo Alto, CA).",9606,"Cy5-sample cRNA and Cy3-common reference cRNA were hybridized to a custom Agilent oligonucleotide microarray, containing a total of 21,619 spots corresponding to 18,175 unique genes, followed by confocal laser scanning (Agilent Technologies).",Scanned on an Agilent G2565AA scanner.,Images were quantified using Agilent Feature Extraction Software (version A.7.5).,n/a,"LOWESS normalized, background subtracted VALUE data obtained from log10 of processed Red signal/processed Green signal. Agilent software was used.",GPL7015,"Takashi,,Takahashi",Aichi Cancer Center,"1-1 Kanokoden, Chikusa-ku",Nagoya,Aichi,464-8681,Japan,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM303nnn/GSM303048/suppl/GSM303048.txt.gz,21619,64,AD053,-,Wt,Y,Non-TRU,,Moderately,AD,Definite,Mut,Positive,Mut,114,19,IIIA,T2N2M0,M,LN (neck),1540,Dead,784
GSM303049,Patient 054 with adenocarcinoma,GSM303049,Public on Apr 01 2009,Jul 02 2008,Jul 02 2008,RNA,2,Primary lung tumor,Homo sapiens,Annotation: AD054,Position in Figure 1 (L to R): 113,Age: 53,Sex: F,Histology: AD,Smoking (BI): 835,pTNM: T4N2M0,pStage: IIIB,Status: Dead,Survival (days): 596,Evidence of relapse: N,Site of relapse:,EGFR status: Wt,K-ras Status: Wt,p53 Status: Wt,Gefitinib treatment:,Position in Figure 2 (L to R): 18,Expression profile-based classification: Non-TRU,Invasion: Definite,Necrosis: Negative,Grade: Poorly,BAC features: -,total RNA,"Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 250 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.",Cy5,"cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescent Linear Amplification kit (Agilent Technologies, Palo Alto, CA).",9606,"Total RNA from 20 lung cell lines representing all major histological types of lung cancers, labeled with Cyanine-3 (green).",Homo sapiens,n/a,total RNA,"Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 250 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.",Cy3,"cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescent Linear Amplification kit (Agilent Technologies, Palo Alto, CA).",9606,"Cy5-sample cRNA and Cy3-common reference cRNA were hybridized to a custom Agilent oligonucleotide microarray, containing a total of 21,619 spots corresponding to 18,175 unique genes, followed by confocal laser scanning (Agilent Technologies).",Scanned on an Agilent G2565AA scanner.,Images were quantified using Agilent Feature Extraction Software (version A.7.5).,n/a,"LOWESS normalized, background subtracted VALUE data obtained from log10 of processed Red signal/processed Green signal. Agilent software was used.",GPL7015,"Takashi,,Takahashi",Aichi Cancer Center,"1-1 Kanokoden, Chikusa-ku",Nagoya,Aichi,464-8681,Japan,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM303nnn/GSM303049/suppl/GSM303049.txt.gz,21619,53,AD054,-,Wt,N,Non-TRU,,Poorly,AD,Definite,Wt,Negative,Wt,113,18,IIIB,T4N2M0,F,,835,Dead,596
GSM303050,Patient 055 with adenocarcinoma,GSM303050,Public on Apr 01 2009,Jul 02 2008,Jul 02 2008,RNA,2,Primary lung tumor,Homo sapiens,Annotation: AD055,Position in Figure 1 (L to R): 129,Age: 53,Sex: F,Histology: AD,Smoking (BI): 120,pTNM: T1N2M0,pStage: IIIA,Status: Alive,Survival (days): 2520,Evidence of relapse: N,Site of relapse:,EGFR status: Mut,K-ras Status: Wt,p53 Status: Mut,Gefitinib treatment:,Position in Figure 2 (L to R): 31,Expression profile-based classification: Non-TRU,Invasion: Definite,Necrosis: Negative,Grade: Moderately,BAC features: -,total RNA,"Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 250 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.",Cy5,"cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescent Linear Amplification kit (Agilent Technologies, Palo Alto, CA).",9606,"Total RNA from 20 lung cell lines representing all major histological types of lung cancers, labeled with Cyanine-3 (green).",Homo sapiens,n/a,total RNA,"Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 250 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.",Cy3,"cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescent Linear Amplification kit (Agilent Technologies, Palo Alto, CA).",9606,"Cy5-sample cRNA and Cy3-common reference cRNA were hybridized to a custom Agilent oligonucleotide microarray, containing a total of 21,619 spots corresponding to 18,175 unique genes, followed by confocal laser scanning (Agilent Technologies).",Scanned on an Agilent G2565AA scanner.,Images were quantified using Agilent Feature Extraction Software (version A.7.5).,n/a,"LOWESS normalized, background subtracted VALUE data obtained from log10 of processed Red signal/processed Green signal. Agilent software was used.",GPL7015,"Takashi,,Takahashi",Aichi Cancer Center,"1-1 Kanokoden, Chikusa-ku",Nagoya,Aichi,464-8681,Japan,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM303nnn/GSM303050/suppl/GSM303050.txt.gz,21619,53,AD055,-,Mut,N,Non-TRU,,Moderately,AD,Definite,Wt,Negative,Mut,129,31,IIIA,T1N2M0,F,,120,Alive,2520
GSM303051,Patient 056 with adenocarcinoma,GSM303051,Public on Apr 01 2009,Jul 02 2008,Jul 02 2008,RNA,2,Primary lung tumor,Homo sapiens,Annotation: AD056,Position in Figure 1 (L to R): 136,Age: 62,Sex: F,Histology: AD,Smoking (BI): 0,pTNM: T2N0M0,pStage: IB,Status: Dead,Survival (days): 2347,Evidence of relapse: Y,Site of relapse: PM,EGFR status: Wt,K-ras Status: Wt,p53 Status: Wt,Gefitinib treatment: Y,Position in Figure 2 (L to R): 74,Expression profile-based classification: TRU-b,Invasion: Not obvious,Necrosis: Negative,Grade: Well,BAC features: +,total RNA,"Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 250 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.",Cy5,"cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescent Linear Amplification kit (Agilent Technologies, Palo Alto, CA).",9606,"Total RNA from 20 lung cell lines representing all major histological types of lung cancers, labeled with Cyanine-3 (green).",Homo sapiens,n/a,total RNA,"Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 250 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.",Cy3,"cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescent Linear Amplification kit (Agilent Technologies, Palo Alto, CA).",9606,"Cy5-sample cRNA and Cy3-common reference cRNA were hybridized to a custom Agilent oligonucleotide microarray, containing a total of 21,619 spots corresponding to 18,175 unique genes, followed by confocal laser scanning (Agilent Technologies).",Scanned on an Agilent G2565AA scanner.,Images were quantified using Agilent Feature Extraction Software (version A.7.5).,n/a,"LOWESS normalized, background subtracted VALUE data obtained from log10 of processed Red signal/processed Green signal. Agilent software was used.",GPL7015,"Takashi,,Takahashi",Aichi Cancer Center,"1-1 Kanokoden, Chikusa-ku",Nagoya,Aichi,464-8681,Japan,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM303nnn/GSM303051/suppl/GSM303051.txt.gz,21619,62,AD056,+,Wt,Y,TRU-b,Y,Well,AD,Not obvious,Wt,Negative,Wt,136,74,IB,T2N0M0,F,PM,0,Dead,2347
GSM303052,Patient 057 with adenocarcinoma,GSM303052,Public on Apr 01 2009,Jul 02 2008,Jul 02 2008,RNA,2,Primary lung tumor,Homo sapiens,Annotation: AD057,Position in Figure 1 (L to R): 127,Age: 73,Sex: F,Histology: AD,Smoking (BI): 0,pTNM: T2N0M0,pStage: IB,Status: Dead,Survival (days): 1880,Evidence of relapse: Y,Site of relapse: Local rec.,EGFR status: Mut,K-ras Status: Wt,p53 Status: Wt,Gefitinib treatment: Y,Position in Figure 2 (L to R): 28,Expression profile-based classification: Non-TRU,Invasion: Not obvious,Necrosis: Negative,Grade: Well,BAC features: -,total RNA,"Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 250 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.",Cy5,"cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescent Linear Amplification kit (Agilent Technologies, Palo Alto, CA).",9606,"Total RNA from 20 lung cell lines representing all major histological types of lung cancers, labeled with Cyanine-3 (green).",Homo sapiens,n/a,total RNA,"Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 250 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.",Cy3,"cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescent Linear Amplification kit (Agilent Technologies, Palo Alto, CA).",9606,"Cy5-sample cRNA and Cy3-common reference cRNA were hybridized to a custom Agilent oligonucleotide microarray, containing a total of 21,619 spots corresponding to 18,175 unique genes, followed by confocal laser scanning (Agilent Technologies).",Scanned on an Agilent G2565AA scanner.,Images were quantified using Agilent Feature Extraction Software (version A.7.5).,n/a,"LOWESS normalized, background subtracted VALUE data obtained from log10 of processed Red signal/processed Green signal. Agilent software was used.",GPL7015,"Takashi,,Takahashi",Aichi Cancer Center,"1-1 Kanokoden, Chikusa-ku",Nagoya,Aichi,464-8681,Japan,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM303nnn/GSM303052/suppl/GSM303052.txt.gz,21619,73,AD057,-,Mut,Y,Non-TRU,Y,Well,AD,Not obvious,Wt,Negative,Wt,127,28,IB,T2N0M0,F,Local rec.,0,Dead,1880
GSM303053,Patient 058 with adenocarcinoma,GSM303053,Public on Apr 01 2009,Jul 02 2008,Jul 02 2008,RNA,2,Primary lung tumor,Homo sapiens,Annotation: AD058,Position in Figure 1 (L to R): 121,Age: 47,Sex: M,Histology: AD,Smoking (BI): 800,pTNM: T1N0M0,pStage: IA,Status: Dead,Survival (days): 2050,Evidence of relapse: Y,Site of relapse: Brain,EGFR status: Wt,K-ras Status: Mut,p53 Status: Mut,Gefitinib treatment: Y,Position in Figure 2 (L to R): 26,Expression profile-based classification: Non-TRU,Invasion: Definite,Necrosis: Focal,Grade: Moderately,BAC features: -,total RNA,"Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 250 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.",Cy5,"cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescent Linear Amplification kit (Agilent Technologies, Palo Alto, CA).",9606,"Total RNA from 20 lung cell lines representing all major histological types of lung cancers, labeled with Cyanine-3 (green).",Homo sapiens,n/a,total RNA,"Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 250 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.",Cy3,"cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescent Linear Amplification kit (Agilent Technologies, Palo Alto, CA).",9606,"Cy5-sample cRNA and Cy3-common reference cRNA were hybridized to a custom Agilent oligonucleotide microarray, containing a total of 21,619 spots corresponding to 18,175 unique genes, followed by confocal laser scanning (Agilent Technologies).",Scanned on an Agilent G2565AA scanner.,Images were quantified using Agilent Feature Extraction Software (version A.7.5).,n/a,"LOWESS normalized, background subtracted VALUE data obtained from log10 of processed Red signal/processed Green signal. Agilent software was used.",GPL7015,"Takashi,,Takahashi",Aichi Cancer Center,"1-1 Kanokoden, Chikusa-ku",Nagoya,Aichi,464-8681,Japan,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM303nnn/GSM303053/suppl/GSM303053.txt.gz,21619,47,AD058,-,Wt,Y,Non-TRU,Y,Moderately,AD,Definite,Mut,Focal,Mut,121,26,IA,T1N0M0,M,Brain,800,Dead,2050
GSM303054,Patient 059 with adenocarcinoma,GSM303054,Public on Apr 01 2009,Jul 02 2008,Jul 02 2008,RNA,2,Primary lung tumor,Homo sapiens,Annotation: AD059,Position in Figure 1 (L to R): 146,Age: 74,Sex: M,Histology: AD,Smoking (BI): 1060,pTNM: T2N0M0,pStage: IB,Status: Alive,Survival (days): 2072,Evidence of relapse: N,Site of relapse:,EGFR status: Wt,K-ras Status: Wt,p53 Status: Wt,Gefitinib treatment:,Position in Figure 2 (L to R): 22,Expression profile-based classification: Non-TRU,Invasion: Definite,Necrosis: Negative,Grade: Poorly,BAC features: -,total RNA,"Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 250 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.",Cy5,"cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescent Linear Amplification kit (Agilent Technologies, Palo Alto, CA).",9606,"Total RNA from 20 lung cell lines representing all major histological types of lung cancers, labeled with Cyanine-3 (green).",Homo sapiens,n/a,total RNA,"Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 250 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.",Cy3,"cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescent Linear Amplification kit (Agilent Technologies, Palo Alto, CA).",9606,"Cy5-sample cRNA and Cy3-common reference cRNA were hybridized to a custom Agilent oligonucleotide microarray, containing a total of 21,619 spots corresponding to 18,175 unique genes, followed by confocal laser scanning (Agilent Technologies).",Scanned on an Agilent G2565AA scanner.,Images were quantified using Agilent Feature Extraction Software (version A.7.5).,n/a,"LOWESS normalized, background subtracted VALUE data obtained from log10 of processed Red signal/processed Green signal. Agilent software was used.",GPL7015,"Takashi,,Takahashi",Aichi Cancer Center,"1-1 Kanokoden, Chikusa-ku",Nagoya,Aichi,464-8681,Japan,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM303nnn/GSM303054/suppl/GSM303054.txt.gz,21619,74,AD059,-,Wt,N,Non-TRU,,Poorly,AD,Definite,Wt,Negative,Wt,146,22,IB,T2N0M0,M,,1060,Alive,2072
GSM303055,Patient 060 with adenocarcinoma,GSM303055,Public on Apr 01 2009,Jul 02 2008,Jul 02 2008,RNA,2,Primary lung tumor,Homo sapiens,Annotation: AD060,Position in Figure 1 (L to R): 148,Age: 56,Sex: M,Histology: AD,Smoking (BI): 1260,pTNM: T2N0M0,pStage: IB,Status: Dead,Survival (days): 440,Evidence of relapse: Y,Site of relapse: LN (neck),EGFR status: Wt,K-ras Status: Wt,p53 Status: Mut,Gefitinib treatment:,Position in Figure 2 (L to R): 34,Expression profile-based classification: Non-TRU,Invasion: Definite,Necrosis: Positive,Grade: Poorly,BAC features: -,total RNA,"Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 250 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.",Cy5,"cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescent Linear Amplification kit (Agilent Technologies, Palo Alto, CA).",9606,"Total RNA from 20 lung cell lines representing all major histological types of lung cancers, labeled with Cyanine-3 (green).",Homo sapiens,n/a,total RNA,"Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 250 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.",Cy3,"cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescent Linear Amplification kit (Agilent Technologies, Palo Alto, CA).",9606,"Cy5-sample cRNA and Cy3-common reference cRNA were hybridized to a custom Agilent oligonucleotide microarray, containing a total of 21,619 spots corresponding to 18,175 unique genes, followed by confocal laser scanning (Agilent Technologies).",Scanned on an Agilent G2565AA scanner.,Images were quantified using Agilent Feature Extraction Software (version A.7.5).,n/a,"LOWESS normalized, background subtracted VALUE data obtained from log10 of processed Red signal/processed Green signal. Agilent software was used.",GPL7015,"Takashi,,Takahashi",Aichi Cancer Center,"1-1 Kanokoden, Chikusa-ku",Nagoya,Aichi,464-8681,Japan,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM303nnn/GSM303055/suppl/GSM303055.txt.gz,21619,56,AD060,-,Wt,Y,Non-TRU,,Poorly,AD,Definite,Wt,Positive,Mut,148,34,IB,T2N0M0,M,LN (neck),1260,Dead,440
GSM303056,Patient 061 with adenocarcinoma,GSM303056,Public on Apr 01 2009,Jul 02 2008,Jul 02 2008,RNA,2,Primary lung tumor,Homo sapiens,Annotation: AD061,Position in Figure 1 (L to R): 128,Age: 69,Sex: M,Histology: AD,Smoking (BI): 675,pTNM: T1N0M0,pStage: IA,Status: Alive,Survival (days): 2525,Evidence of relapse: N,Site of relapse:,EGFR status: Wt,K-ras Status: Wt,p53 Status: Wt,Gefitinib treatment:,Position in Figure 2 (L to R): 4,Expression profile-based classification: Non-TRU,Invasion: Definite,Necrosis: Negative,Grade: Moderately,BAC features: +,total RNA,"Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 250 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.",Cy5,"cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescent Linear Amplification kit (Agilent Technologies, Palo Alto, CA).",9606,"Total RNA from 20 lung cell lines representing all major histological types of lung cancers, labeled with Cyanine-3 (green).",Homo sapiens,n/a,total RNA,"Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 250 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.",Cy3,"cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescent Linear Amplification kit (Agilent Technologies, Palo Alto, CA).",9606,"Cy5-sample cRNA and Cy3-common reference cRNA were hybridized to a custom Agilent oligonucleotide microarray, containing a total of 21,619 spots corresponding to 18,175 unique genes, followed by confocal laser scanning (Agilent Technologies).",Scanned on an Agilent G2565AA scanner.,Images were quantified using Agilent Feature Extraction Software (version A.7.5).,n/a,"LOWESS normalized, background subtracted VALUE data obtained from log10 of processed Red signal/processed Green signal. Agilent software was used.",GPL7015,"Takashi,,Takahashi",Aichi Cancer Center,"1-1 Kanokoden, Chikusa-ku",Nagoya,Aichi,464-8681,Japan,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM303nnn/GSM303056/suppl/GSM303056.txt.gz,21619,69,AD061,+,Wt,N,Non-TRU,,Moderately,AD,Definite,Wt,Negative,Wt,128,4,IA,T1N0M0,M,,675,Alive,2525
GSM303057,Patient 062 with adenocarcinoma,GSM303057,Public on Apr 01 2009,Jul 02 2008,Jul 02 2008,RNA,2,Primary lung tumor,Homo sapiens,Annotation: AD062,Position in Figure 1 (L to R): 111,Age: 68,Sex: M,Histology: AD,Smoking (BI): 570,pTNM: T1N1M0,pStage: IIA,Status: Dead,Survival (days): 482,Evidence of relapse: Y,Site of relapse: Liver,EGFR status: Wt,K-ras Status: Wt,p53 Status: Wt,Gefitinib treatment:,Position in Figure 2 (L to R): 10,Expression profile-based classification: Non-TRU,Invasion: Definite,Necrosis: Positive,Grade: Poorly,BAC features: -,total RNA,"Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 250 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.",Cy5,"cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescent Linear Amplification kit (Agilent Technologies, Palo Alto, CA).",9606,"Total RNA from 20 lung cell lines representing all major histological types of lung cancers, labeled with Cyanine-3 (green).",Homo sapiens,n/a,total RNA,"Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 250 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.",Cy3,"cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescent Linear Amplification kit (Agilent Technologies, Palo Alto, CA).",9606,"Cy5-sample cRNA and Cy3-common reference cRNA were hybridized to a custom Agilent oligonucleotide microarray, containing a total of 21,619 spots corresponding to 18,175 unique genes, followed by confocal laser scanning (Agilent Technologies).",Scanned on an Agilent G2565AA scanner.,Images were quantified using Agilent Feature Extraction Software (version A.7.5).,n/a,"LOWESS normalized, background subtracted VALUE data obtained from log10 of processed Red signal/processed Green signal. Agilent software was used.",GPL7015,"Takashi,,Takahashi",Aichi Cancer Center,"1-1 Kanokoden, Chikusa-ku",Nagoya,Aichi,464-8681,Japan,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM303nnn/GSM303057/suppl/GSM303057.txt.gz,21619,68,AD062,-,Wt,Y,Non-TRU,,Poorly,AD,Definite,Wt,Positive,Wt,111,10,IIA,T1N1M0,M,Liver,570,Dead,482
GSM303058,Patient 063 with adenocarcinoma,GSM303058,Public on Apr 01 2009,Jul 02 2008,Jul 02 2008,RNA,2,Primary lung tumor,Homo sapiens,Annotation: AD063,Position in Figure 1 (L to R): 126,Age: 41,Sex: M,Histology: AD,Smoking (BI): 60,pTNM: T1N0M0,pStage: IA,Status: Dead,Survival (days): 1164,Evidence of relapse: Y,Site of relapse: PM,EGFR status: Mut,K-ras Status: Wt,p53 Status: Mut,Gefitinib treatment:,Position in Figure 2 (L to R): 30,Expression profile-based classification: Non-TRU,Invasion: Definite,Necrosis: Negative,Grade: Moderately,BAC features: -,total RNA,"Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 250 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.",Cy5,"cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescent Linear Amplification kit (Agilent Technologies, Palo Alto, CA).",9606,"Total RNA from 20 lung cell lines representing all major histological types of lung cancers, labeled with Cyanine-3 (green).",Homo sapiens,n/a,total RNA,"Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 250 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.",Cy3,"cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescent Linear Amplification kit (Agilent Technologies, Palo Alto, CA).",9606,"Cy5-sample cRNA and Cy3-common reference cRNA were hybridized to a custom Agilent oligonucleotide microarray, containing a total of 21,619 spots corresponding to 18,175 unique genes, followed by confocal laser scanning (Agilent Technologies).",Scanned on an Agilent G2565AA scanner.,Images were quantified using Agilent Feature Extraction Software (version A.7.5).,n/a,"LOWESS normalized, background subtracted VALUE data obtained from log10 of processed Red signal/processed Green signal. Agilent software was used.",GPL7015,"Takashi,,Takahashi",Aichi Cancer Center,"1-1 Kanokoden, Chikusa-ku",Nagoya,Aichi,464-8681,Japan,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM303nnn/GSM303058/suppl/GSM303058.txt.gz,21619,41,AD063,-,Mut,Y,Non-TRU,,Moderately,AD,Definite,Wt,Negative,Mut,126,30,IA,T1N0M0,M,PM,60,Dead,1164
GSM303059,Patient 064 with adenocarcinoma,GSM303059,Public on Apr 01 2009,Jul 02 2008,Jul 02 2008,RNA,2,Primary lung tumor,Homo sapiens,Annotation: AD064,Position in Figure 1 (L to R): 123,Age: 55,Sex: M,Histology: AD,Smoking (BI): 1440,pTNM: T1N0M0,pStage: IA,Status: Alive,Survival (days): 2533,Evidence of relapse: N,Site of relapse:,EGFR status: Wt,K-ras Status: Wt,p53 Status: Wt,Gefitinib treatment:,Position in Figure 2 (L to R): 3,Expression profile-based classification: Non-TRU,Invasion: Definite,Necrosis: Negative,Grade: Poorly,BAC features: -,total RNA,"Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 250 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.",Cy5,"cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescent Linear Amplification kit (Agilent Technologies, Palo Alto, CA).",9606,"Total RNA from 20 lung cell lines representing all major histological types of lung cancers, labeled with Cyanine-3 (green).",Homo sapiens,n/a,total RNA,"Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 250 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.",Cy3,"cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescent Linear Amplification kit (Agilent Technologies, Palo Alto, CA).",9606,"Cy5-sample cRNA and Cy3-common reference cRNA were hybridized to a custom Agilent oligonucleotide microarray, containing a total of 21,619 spots corresponding to 18,175 unique genes, followed by confocal laser scanning (Agilent Technologies).",Scanned on an Agilent G2565AA scanner.,Images were quantified using Agilent Feature Extraction Software (version A.7.5).,n/a,"LOWESS normalized, background subtracted VALUE data obtained from log10 of processed Red signal/processed Green signal. Agilent software was used.",GPL7015,"Takashi,,Takahashi",Aichi Cancer Center,"1-1 Kanokoden, Chikusa-ku",Nagoya,Aichi,464-8681,Japan,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM303nnn/GSM303059/suppl/GSM303059.txt.gz,21619,55,AD064,-,Wt,N,Non-TRU,,Poorly,AD,Definite,Wt,Negative,Wt,123,3,IA,T1N0M0,M,,1440,Alive,2533
GSM303060,Patient 065 with adenocarcinoma,GSM303060,Public on Apr 01 2009,Jul 02 2008,Jul 02 2008,RNA,2,Primary lung tumor,Homo sapiens,Annotation: AD065,Position in Figure 1 (L to R): 125,Age: 60,Sex: F,Histology: AD,Smoking (BI): 0,pTNM: T1N0M0,pStage: IA,Status: Alive,Survival (days): 2528,Evidence of relapse: N,Site of relapse:,EGFR status: Wt,K-ras Status: Wt,p53 Status: Mut,Gefitinib treatment:,Position in Figure 2 (L to R): 29,Expression profile-based classification: Non-TRU,Invasion: Definite,Necrosis: Focal,Grade: Moderately,BAC features: +,total RNA,"Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 250 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.",Cy5,"cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescent Linear Amplification kit (Agilent Technologies, Palo Alto, CA).",9606,"Total RNA from 20 lung cell lines representing all major histological types of lung cancers, labeled with Cyanine-3 (green).",Homo sapiens,n/a,total RNA,"Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 250 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.",Cy3,"cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescent Linear Amplification kit (Agilent Technologies, Palo Alto, CA).",9606,"Cy5-sample cRNA and Cy3-common reference cRNA were hybridized to a custom Agilent oligonucleotide microarray, containing a total of 21,619 spots corresponding to 18,175 unique genes, followed by confocal laser scanning (Agilent Technologies).",Scanned on an Agilent G2565AA scanner.,Images were quantified using Agilent Feature Extraction Software (version A.7.5).,n/a,"LOWESS normalized, background subtracted VALUE data obtained from log10 of processed Red signal/processed Green signal. Agilent software was used.",GPL7015,"Takashi,,Takahashi",Aichi Cancer Center,"1-1 Kanokoden, Chikusa-ku",Nagoya,Aichi,464-8681,Japan,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM303nnn/GSM303060/suppl/GSM303060.txt.gz,21619,60,AD065,+,Wt,N,Non-TRU,,Moderately,AD,Definite,Wt,Focal,Mut,125,29,IA,T1N0M0,F,,0,Alive,2528
GSM303061,Patient 066 with adenocarcinoma,GSM303061,Public on Apr 01 2009,Jul 02 2008,Jul 02 2008,RNA,2,Primary lung tumor,Homo sapiens,Annotation: AD066,Position in Figure 1 (L to R): 135,Age: 66,Sex: M,Histology: AD,Smoking (BI): 0,pTNM: T1N0M0,pStage: IA,Status: Alive,Survival (days): 2353,Evidence of relapse: N,Site of relapse:,EGFR status: Mut,K-ras Status: Wt,p53 Status: Wt,Gefitinib treatment:,Position in Figure 2 (L to R): 77,Expression profile-based classification: TRU-b,Invasion: Definite but focal,Necrosis: Negative,Grade: Well,BAC features: +,total RNA,"Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 250 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.",Cy5,"cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescent Linear Amplification kit (Agilent Technologies, Palo Alto, CA).",9606,"Total RNA from 20 lung cell lines representing all major histological types of lung cancers, labeled with Cyanine-3 (green).",Homo sapiens,n/a,total RNA,"Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 250 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.",Cy3,"cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescent Linear Amplification kit (Agilent Technologies, Palo Alto, CA).",9606,"Cy5-sample cRNA and Cy3-common reference cRNA were hybridized to a custom Agilent oligonucleotide microarray, containing a total of 21,619 spots corresponding to 18,175 unique genes, followed by confocal laser scanning (Agilent Technologies).",Scanned on an Agilent G2565AA scanner.,Images were quantified using Agilent Feature Extraction Software (version A.7.5).,n/a,"LOWESS normalized, background subtracted VALUE data obtained from log10 of processed Red signal/processed Green signal. Agilent software was used.",GPL7015,"Takashi,,Takahashi",Aichi Cancer Center,"1-1 Kanokoden, Chikusa-ku",Nagoya,Aichi,464-8681,Japan,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM303nnn/GSM303061/suppl/GSM303061.txt.gz,21619,66,AD066,+,Mut,N,TRU-b,,Well,AD,Definite but focal,Wt,Negative,Wt,135,77,IA,T1N0M0,M,,0,Alive,2353
GSM303062,Patient 067 with adenocarcinoma,GSM303062,Public on Apr 01 2009,Jul 02 2008,Jul 02 2008,RNA,2,Primary lung tumor,Homo sapiens,Annotation: AD067,Position in Figure 1 (L to R): 143,Age: 42,Sex: F,Histology: AD,Smoking (BI): 0,pTNM: T1N0M0,pStage: IA,Status: Alive,Survival (days): 2507,Evidence of relapse: N,Site of relapse:,EGFR status: Wt,K-ras Status: Wt,p53 Status: Wt,Gefitinib treatment:,Position in Figure 2 (L to R): 76,Expression profile-based classification: TRU-b,Invasion: Not obvious,Necrosis: Negative,Grade: Well,BAC features: +,total RNA,"Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 250 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.",Cy5,"cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescent Linear Amplification kit (Agilent Technologies, Palo Alto, CA).",9606,"Total RNA from 20 lung cell lines representing all major histological types of lung cancers, labeled with Cyanine-3 (green).",Homo sapiens,n/a,total RNA,"Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 250 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.",Cy3,"cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescent Linear Amplification kit (Agilent Technologies, Palo Alto, CA).",9606,"Cy5-sample cRNA and Cy3-common reference cRNA were hybridized to a custom Agilent oligonucleotide microarray, containing a total of 21,619 spots corresponding to 18,175 unique genes, followed by confocal laser scanning (Agilent Technologies).",Scanned on an Agilent G2565AA scanner.,Images were quantified using Agilent Feature Extraction Software (version A.7.5).,n/a,"LOWESS normalized, background subtracted VALUE data obtained from log10 of processed Red signal/processed Green signal. Agilent software was used.",GPL7015,"Takashi,,Takahashi",Aichi Cancer Center,"1-1 Kanokoden, Chikusa-ku",Nagoya,Aichi,464-8681,Japan,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM303nnn/GSM303062/suppl/GSM303062.txt.gz,21619,42,AD067,+,Wt,N,TRU-b,,Well,AD,Not obvious,Wt,Negative,Wt,143,76,IA,T1N0M0,F,,0,Alive,2507
GSM303063,Patient 068 with adenocarcinoma,GSM303063,Public on Apr 01 2009,Jul 02 2008,Jul 02 2008,RNA,2,Primary lung tumor,Homo sapiens,Annotation: AD068,Position in Figure 1 (L to R): 116,Age: 56,Sex: M,Histology: AD,Smoking (BI): 720,pTNM: T3N0M0,pStage: IIB,Status: Alive,Survival (days): 2519,Evidence of relapse: Y,Site of relapse: PM?bone,EGFR status: Mut,K-ras Status: Wt,p53 Status: Wt,Gefitinib treatment: Y,Position in Figure 2 (L to R): 27,Expression profile-based classification: Non-TRU,Invasion: Definite,Necrosis: Negative,Grade: Moderately,BAC features: -,total RNA,"Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 250 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.",Cy5,"cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescent Linear Amplification kit (Agilent Technologies, Palo Alto, CA).",9606,"Total RNA from 20 lung cell lines representing all major histological types of lung cancers, labeled with Cyanine-3 (green).",Homo sapiens,n/a,total RNA,"Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 250 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.",Cy3,"cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescent Linear Amplification kit (Agilent Technologies, Palo Alto, CA).",9606,"Cy5-sample cRNA and Cy3-common reference cRNA were hybridized to a custom Agilent oligonucleotide microarray, containing a total of 21,619 spots corresponding to 18,175 unique genes, followed by confocal laser scanning (Agilent Technologies).",Scanned on an Agilent G2565AA scanner.,Images were quantified using Agilent Feature Extraction Software (version A.7.5).,n/a,"LOWESS normalized, background subtracted VALUE data obtained from log10 of processed Red signal/processed Green signal. Agilent software was used.",GPL7015,"Takashi,,Takahashi",Aichi Cancer Center,"1-1 Kanokoden, Chikusa-ku",Nagoya,Aichi,464-8681,Japan,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM303nnn/GSM303063/suppl/GSM303063.txt.gz,21619,56,AD068,-,Mut,Y,Non-TRU,Y,Moderately,AD,Definite,Wt,Negative,Wt,116,27,IIB,T3N0M0,M,PM?bone,720,Alive,2519
GSM303064,Patient 069 with adenocarcinoma,GSM303064,Public on Apr 01 2009,Jul 02 2008,Jul 02 2008,RNA,2,Primary lung tumor,Homo sapiens,Annotation: AD069,Position in Figure 1 (L to R): 120,Age: 50,Sex: F,Histology: AD,Smoking (BI): 0,pTNM: T1N0M0,pStage: IA,Status: Alive,Survival (days): 2521,Evidence of relapse: Y,Site of relapse: PM,EGFR status: Mut,K-ras Status: Wt,p53 Status: Mut,Gefitinib treatment: Y,Position in Figure 2 (L to R): 25,Expression profile-based classification: Non-TRU,Invasion: Definite,Necrosis: Focal,Grade: Well,BAC features: -,total RNA,"Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 250 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.",Cy5,"cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescent Linear Amplification kit (Agilent Technologies, Palo Alto, CA).",9606,"Total RNA from 20 lung cell lines representing all major histological types of lung cancers, labeled with Cyanine-3 (green).",Homo sapiens,n/a,total RNA,"Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 250 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.",Cy3,"cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescent Linear Amplification kit (Agilent Technologies, Palo Alto, CA).",9606,"Cy5-sample cRNA and Cy3-common reference cRNA were hybridized to a custom Agilent oligonucleotide microarray, containing a total of 21,619 spots corresponding to 18,175 unique genes, followed by confocal laser scanning (Agilent Technologies).",Scanned on an Agilent G2565AA scanner.,Images were quantified using Agilent Feature Extraction Software (version A.7.5).,n/a,"LOWESS normalized, background subtracted VALUE data obtained from log10 of processed Red signal/processed Green signal. Agilent software was used.",GPL7015,"Takashi,,Takahashi",Aichi Cancer Center,"1-1 Kanokoden, Chikusa-ku",Nagoya,Aichi,464-8681,Japan,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM303nnn/GSM303064/suppl/GSM303064.txt.gz,21619,50,AD069,-,Mut,Y,Non-TRU,Y,Well,AD,Definite,Wt,Focal,Mut,120,25,IA,T1N0M0,F,PM,0,Alive,2521
GSM303065,Patient 070 with adenocarcinoma,GSM303065,Public on Apr 01 2009,Jul 02 2008,Jul 02 2008,RNA,2,Primary lung tumor,Homo sapiens,Annotation: AD070,Position in Figure 1 (L to R): 145,Age: 70,Sex: F,Histology: AD,Smoking (BI): 400,pTNM: T1N2M0,pStage: IIIA,Status: Dead,Survival (days): 1501,Evidence of relapse: Y,Site of relapse: Bone,EGFR status: Mut,K-ras Status: Wt,p53 Status: Mut,Gefitinib treatment:,Position in Figure 2 (L to R): 88,Expression profile-based classification: TRU-b,Invasion: Definite,Necrosis: Negative,Grade: Well,BAC features: -,total RNA,"Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 250 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.",Cy5,"cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescent Linear Amplification kit (Agilent Technologies, Palo Alto, CA).",9606,"Total RNA from 20 lung cell lines representing all major histological types of lung cancers, labeled with Cyanine-3 (green).",Homo sapiens,n/a,total RNA,"Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 250 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.",Cy3,"cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescent Linear Amplification kit (Agilent Technologies, Palo Alto, CA).",9606,"Cy5-sample cRNA and Cy3-common reference cRNA were hybridized to a custom Agilent oligonucleotide microarray, containing a total of 21,619 spots corresponding to 18,175 unique genes, followed by confocal laser scanning (Agilent Technologies).",Scanned on an Agilent G2565AA scanner.,Images were quantified using Agilent Feature Extraction Software (version A.7.5).,n/a,"LOWESS normalized, background subtracted VALUE data obtained from log10 of processed Red signal/processed Green signal. Agilent software was used.",GPL7015,"Takashi,,Takahashi",Aichi Cancer Center,"1-1 Kanokoden, Chikusa-ku",Nagoya,Aichi,464-8681,Japan,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM303nnn/GSM303065/suppl/GSM303065.txt.gz,21619,70,AD070,-,Mut,Y,TRU-b,,Well,AD,Definite,Wt,Negative,Mut,145,88,IIIA,T1N2M0,F,Bone,400,Dead,1501
GSM303066,Patient 071 with adenocarcinoma,GSM303066,Public on Apr 01 2009,Jul 02 2008,Jul 02 2008,RNA,2,Primary lung tumor,Homo sapiens,Annotation: AD071,Position in Figure 1 (L to R): 144,Age: 61,Sex: M,Histology: AD,Smoking (BI): 0,pTNM: T1N0M0,pStage: IA,Status: Alive,Survival (days): 2260,Evidence of relapse: N,Site of relapse:,EGFR status: Wt,K-ras Status: Wt,p53 Status: Wt,Gefitinib treatment:,Position in Figure 2 (L to R): 87,Expression profile-based classification: TRU-b,Invasion: Negative,Necrosis: Negative,Grade: Well,BAC features: +,total RNA,"Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 250 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.",Cy5,"cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescent Linear Amplification kit (Agilent Technologies, Palo Alto, CA).",9606,"Total RNA from 20 lung cell lines representing all major histological types of lung cancers, labeled with Cyanine-3 (green).",Homo sapiens,n/a,total RNA,"Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 250 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.",Cy3,"cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescent Linear Amplification kit (Agilent Technologies, Palo Alto, CA).",9606,"Cy5-sample cRNA and Cy3-common reference cRNA were hybridized to a custom Agilent oligonucleotide microarray, containing a total of 21,619 spots corresponding to 18,175 unique genes, followed by confocal laser scanning (Agilent Technologies).",Scanned on an Agilent G2565AA scanner.,Images were quantified using Agilent Feature Extraction Software (version A.7.5).,n/a,"LOWESS normalized, background subtracted VALUE data obtained from log10 of processed Red signal/processed Green signal. Agilent software was used.",GPL7015,"Takashi,,Takahashi",Aichi Cancer Center,"1-1 Kanokoden, Chikusa-ku",Nagoya,Aichi,464-8681,Japan,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM303nnn/GSM303066/suppl/GSM303066.txt.gz,21619,61,AD071,+,Wt,N,TRU-b,,Well,AD,Negative,Wt,Negative,Wt,144,87,IA,T1N0M0,M,,0,Alive,2260
GSM303067,Patient 072 with adenocarcinoma,GSM303067,Public on Apr 01 2009,Jul 02 2008,Jul 02 2008,RNA,2,Primary lung tumor,Homo sapiens,Annotation: AD072,Position in Figure 1 (L to R): 93,Age: 63,Sex: M,Histology: AD,Smoking (BI): 900,pTNM: T2N2M0,pStage: IIIA,Status: Alive,Survival (days): 2339,Evidence of relapse: N,Site of relapse:,EGFR status: Wt,K-ras Status: Mut,p53 Status: Wt,Gefitinib treatment:,Position in Figure 2 (L to R): 40,Expression profile-based classification: TRU-a,Invasion: Definite,Necrosis: Focal,Grade: Poorly,BAC features: -,total RNA,"Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 250 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.",Cy5,"cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescent Linear Amplification kit (Agilent Technologies, Palo Alto, CA).",9606,"Total RNA from 20 lung cell lines representing all major histological types of lung cancers, labeled with Cyanine-3 (green).",Homo sapiens,n/a,total RNA,"Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 250 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.",Cy3,"cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescent Linear Amplification kit (Agilent Technologies, Palo Alto, CA).",9606,"Cy5-sample cRNA and Cy3-common reference cRNA were hybridized to a custom Agilent oligonucleotide microarray, containing a total of 21,619 spots corresponding to 18,175 unique genes, followed by confocal laser scanning (Agilent Technologies).",Scanned on an Agilent G2565AA scanner.,Images were quantified using Agilent Feature Extraction Software (version A.7.5).,n/a,"LOWESS normalized, background subtracted VALUE data obtained from log10 of processed Red signal/processed Green signal. Agilent software was used.",GPL7015,"Takashi,,Takahashi",Aichi Cancer Center,"1-1 Kanokoden, Chikusa-ku",Nagoya,Aichi,464-8681,Japan,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM303nnn/GSM303067/suppl/GSM303067.txt.gz,21619,63,AD072,-,Wt,N,TRU-a,,Poorly,AD,Definite,Mut,Focal,Wt,93,40,IIIA,T2N2M0,M,,900,Alive,2339
GSM303068,Patient 073 with adenocarcinoma,GSM303068,Public on Apr 01 2009,Jul 02 2008,Jul 02 2008,RNA,2,Primary lung tumor,Homo sapiens,Annotation: AD073,Position in Figure 1 (L to R): 64,Age: 60,Sex: F,Histology: AD,Smoking (BI): 0,pTNM: T2N0M0,pStage: IB,Status: Dead,Survival (days): 1229,Evidence of relapse: Y,Site of relapse: local rec,EGFR status: Wt,K-ras Status: Wt,p53 Status: Wt,Gefitinib treatment:,Position in Figure 2 (L to R): 52,Expression profile-based classification: TRU-a,Invasion: Definite,Necrosis: Focal,Grade: Poorly,BAC features: +,total RNA,"Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 250 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.",Cy5,"cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescent Linear Amplification kit (Agilent Technologies, Palo Alto, CA).",9606,"Total RNA from 20 lung cell lines representing all major histological types of lung cancers, labeled with Cyanine-3 (green).",Homo sapiens,n/a,total RNA,"Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 250 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.",Cy3,"cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescent Linear Amplification kit (Agilent Technologies, Palo Alto, CA).",9606,"Cy5-sample cRNA and Cy3-common reference cRNA were hybridized to a custom Agilent oligonucleotide microarray, containing a total of 21,619 spots corresponding to 18,175 unique genes, followed by confocal laser scanning (Agilent Technologies).",Scanned on an Agilent G2565AA scanner.,Images were quantified using Agilent Feature Extraction Software (version A.7.5).,n/a,"LOWESS normalized, background subtracted VALUE data obtained from log10 of processed Red signal/processed Green signal. Agilent software was used.",GPL7015,"Takashi,,Takahashi",Aichi Cancer Center,"1-1 Kanokoden, Chikusa-ku",Nagoya,Aichi,464-8681,Japan,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM303nnn/GSM303068/suppl/GSM303068.txt.gz,21619,60,AD073,+,Wt,Y,TRU-a,,Poorly,AD,Definite,Wt,Focal,Wt,64,52,IB,T2N0M0,F,local rec,0,Dead,1229
GSM303069,Patient 074 with adenocarcinoma,GSM303069,Public on Apr 01 2009,Jul 02 2008,Jul 02 2008,RNA,2,Primary lung tumor,Homo sapiens,Annotation: AD074,Position in Figure 1 (L to R): 108,Age: 58,Sex: M,Histology: AD,Smoking (BI): 690,pTNM: T1N0M0,pStage: IA,Status: Alive,Survival (days): 2341,Evidence of relapse: N,Site of relapse:,EGFR status: Wt,K-ras Status: Mut,p53 Status: Wt,Gefitinib treatment:,Position in Figure 2 (L to R): 24,Expression profile-based classification: Non-TRU,Invasion: Definite,Necrosis: Negative,Grade: Moderately,BAC features: -,total RNA,"Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 250 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.",Cy5,"cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescent Linear Amplification kit (Agilent Technologies, Palo Alto, CA).",9606,"Total RNA from 20 lung cell lines representing all major histological types of lung cancers, labeled with Cyanine-3 (green).",Homo sapiens,n/a,total RNA,"Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 250 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.",Cy3,"cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescent Linear Amplification kit (Agilent Technologies, Palo Alto, CA).",9606,"Cy5-sample cRNA and Cy3-common reference cRNA were hybridized to a custom Agilent oligonucleotide microarray, containing a total of 21,619 spots corresponding to 18,175 unique genes, followed by confocal laser scanning (Agilent Technologies).",Scanned on an Agilent G2565AA scanner.,Images were quantified using Agilent Feature Extraction Software (version A.7.5).,n/a,"LOWESS normalized, background subtracted VALUE data obtained from log10 of processed Red signal/processed Green signal. Agilent software was used.",GPL7015,"Takashi,,Takahashi",Aichi Cancer Center,"1-1 Kanokoden, Chikusa-ku",Nagoya,Aichi,464-8681,Japan,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM303nnn/GSM303069/suppl/GSM303069.txt.gz,21619,58,AD074,-,Wt,N,Non-TRU,,Moderately,AD,Definite,Mut,Negative,Wt,108,24,IA,T1N0M0,M,,690,Alive,2341
GSM303070,Patient 075 with adenocarcinoma,GSM303070,Public on Apr 01 2009,Jul 02 2008,Jul 02 2008,RNA,2,Primary lung tumor,Homo sapiens,Annotation: AD075,Position in Figure 1 (L to R): 33,Age: 60,Sex: M,Histology: AD,Smoking (BI): 1200,pTNM: T2N0M0,pStage: IB,Status: Dead,Survival (days): 777,Evidence of relapse: Y,Site of relapse: Local rec.,EGFR status: Wt,K-ras Status: Wt,p53 Status: Mut,Gefitinib treatment:,Position in Figure 2 (L to R): 14,Expression profile-based classification: Non-TRU,Invasion: Definite,Necrosis: Positive,Grade: Poorly,BAC features: -,total RNA,"Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 250 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.",Cy5,"cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescent Linear Amplification kit (Agilent Technologies, Palo Alto, CA).",9606,"Total RNA from 20 lung cell lines representing all major histological types of lung cancers, labeled with Cyanine-3 (green).",Homo sapiens,n/a,total RNA,"Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 250 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.",Cy3,"cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescent Linear Amplification kit (Agilent Technologies, Palo Alto, CA).",9606,"Cy5-sample cRNA and Cy3-common reference cRNA were hybridized to a custom Agilent oligonucleotide microarray, containing a total of 21,619 spots corresponding to 18,175 unique genes, followed by confocal laser scanning (Agilent Technologies).",Scanned on an Agilent G2565AA scanner.,Images were quantified using Agilent Feature Extraction Software (version A.7.5).,n/a,"LOWESS normalized, background subtracted VALUE data obtained from log10 of processed Red signal/processed Green signal. Agilent software was used.",GPL7015,"Takashi,,Takahashi",Aichi Cancer Center,"1-1 Kanokoden, Chikusa-ku",Nagoya,Aichi,464-8681,Japan,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM303nnn/GSM303070/suppl/GSM303070.txt.gz,21619,60,AD075,-,Wt,Y,Non-TRU,,Poorly,AD,Definite,Wt,Positive,Mut,33,14,IB,T2N0M0,M,Local rec.,1200,Dead,777
GSM303071,Patient 076 with adenocarcinoma,GSM303071,Public on Apr 01 2009,Jul 02 2008,Jul 02 2008,RNA,2,Primary lung tumor,Homo sapiens,Annotation: AD076,Position in Figure 1 (L to R): 60,Age: 65,Sex: F,Histology: AD,Smoking (BI): 0,pTNM: T1N0M0,pStage: IA,Status: Dead,Survival (days): 1333,Evidence of relapse: Y,"Site of relapse: Local rec.,Brain",EGFR status: Wt,K-ras Status: Wt,p53 Status: Mut,Gefitinib treatment:,Position in Figure 2 (L to R): 39,Expression profile-based classification: TRU-a,Invasion: Definite but focal,Necrosis: Negative,Grade: Moderately,BAC features: +,total RNA,"Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 250 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.",Cy5,"cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescent Linear Amplification kit (Agilent Technologies, Palo Alto, CA).",9606,"Total RNA from 20 lung cell lines representing all major histological types of lung cancers, labeled with Cyanine-3 (green).",Homo sapiens,n/a,total RNA,"Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 250 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.",Cy3,"cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescent Linear Amplification kit (Agilent Technologies, Palo Alto, CA).",9606,"Cy5-sample cRNA and Cy3-common reference cRNA were hybridized to a custom Agilent oligonucleotide microarray, containing a total of 21,619 spots corresponding to 18,175 unique genes, followed by confocal laser scanning (Agilent Technologies).",Scanned on an Agilent G2565AA scanner.,Images were quantified using Agilent Feature Extraction Software (version A.7.5).,n/a,"LOWESS normalized, background subtracted VALUE data obtained from log10 of processed Red signal/processed Green signal. Agilent software was used.",GPL7015,"Takashi,,Takahashi",Aichi Cancer Center,"1-1 Kanokoden, Chikusa-ku",Nagoya,Aichi,464-8681,Japan,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM303nnn/GSM303071/suppl/GSM303071.txt.gz,21619,65,AD076,+,Wt,Y,TRU-a,,Moderately,AD,Definite but focal,Wt,Negative,Mut,60,39,IA,T1N0M0,F,"Local rec.,Brain",0,Dead,1333
GSM303072,Patient 077 with adenocarcinoma,GSM303072,Public on Apr 01 2009,Jul 02 2008,Jul 02 2008,RNA,2,Primary lung tumor,Homo sapiens,Annotation: AD077,Position in Figure 1 (L to R): 84,Age: 60,Sex: F,Histology: AD,Smoking (BI): 0,pTNM: T1N0M0,pStage: IA,Status: Alive,Survival (days): 2348,Evidence of relapse: N,Site of relapse:,EGFR status: Mut,K-ras Status: Wt,p53 Status: Mut,Gefitinib treatment:,Position in Figure 2 (L to R): 38,Expression profile-based classification: TRU-a,Invasion: Definite but focal,Necrosis: Negative,Grade: Well,BAC features: +,total RNA,"Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 250 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.",Cy5,"cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescent Linear Amplification kit (Agilent Technologies, Palo Alto, CA).",9606,"Total RNA from 20 lung cell lines representing all major histological types of lung cancers, labeled with Cyanine-3 (green).",Homo sapiens,n/a,total RNA,"Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 250 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.",Cy3,"cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescent Linear Amplification kit (Agilent Technologies, Palo Alto, CA).",9606,"Cy5-sample cRNA and Cy3-common reference cRNA were hybridized to a custom Agilent oligonucleotide microarray, containing a total of 21,619 spots corresponding to 18,175 unique genes, followed by confocal laser scanning (Agilent Technologies).",Scanned on an Agilent G2565AA scanner.,Images were quantified using Agilent Feature Extraction Software (version A.7.5).,n/a,"LOWESS normalized, background subtracted VALUE data obtained from log10 of processed Red signal/processed Green signal. Agilent software was used.",GPL7015,"Takashi,,Takahashi",Aichi Cancer Center,"1-1 Kanokoden, Chikusa-ku",Nagoya,Aichi,464-8681,Japan,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM303nnn/GSM303072/suppl/GSM303072.txt.gz,21619,60,AD077,+,Mut,N,TRU-a,,Well,AD,Definite but focal,Wt,Negative,Mut,84,38,IA,T1N0M0,F,,0,Alive,2348
GSM303073,Patient 078 with adenocarcinoma,GSM303073,Public on Apr 01 2009,Jul 02 2008,Jul 02 2008,RNA,2,Primary lung tumor,Homo sapiens,Annotation: AD078,Position in Figure 1 (L to R): 39,Age: 82,Sex: M,Histology: AD,Smoking (BI): 0,pTNM: T2N0M0,pStage: IB,Status: Dead,Survival (days): 1008,Evidence of relapse: Y,Site of relapse: PM,EGFR status: Wt,K-ras Status: Wt,p53 Status: Wt,Gefitinib treatment:,Position in Figure 2 (L to R): 13,Expression profile-based classification: Non-TRU,Invasion: Definite,Necrosis: Positive,Grade: Poorly,BAC features: -,total RNA,"Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 250 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.",Cy5,"cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescent Linear Amplification kit (Agilent Technologies, Palo Alto, CA).",9606,"Total RNA from 20 lung cell lines representing all major histological types of lung cancers, labeled with Cyanine-3 (green).",Homo sapiens,n/a,total RNA,"Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 250 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.",Cy3,"cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescent Linear Amplification kit (Agilent Technologies, Palo Alto, CA).",9606,"Cy5-sample cRNA and Cy3-common reference cRNA were hybridized to a custom Agilent oligonucleotide microarray, containing a total of 21,619 spots corresponding to 18,175 unique genes, followed by confocal laser scanning (Agilent Technologies).",Scanned on an Agilent G2565AA scanner.,Images were quantified using Agilent Feature Extraction Software (version A.7.5).,n/a,"LOWESS normalized, background subtracted VALUE data obtained from log10 of processed Red signal/processed Green signal. Agilent software was used.",GPL7015,"Takashi,,Takahashi",Aichi Cancer Center,"1-1 Kanokoden, Chikusa-ku",Nagoya,Aichi,464-8681,Japan,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM303nnn/GSM303073/suppl/GSM303073.txt.gz,21619,82,AD078,-,Wt,Y,Non-TRU,,Poorly,AD,Definite,Wt,Positive,Wt,39,13,IB,T2N0M0,M,PM,0,Dead,1008
GSM303074,Patient 079 with adenocarcinoma,GSM303074,Public on Apr 01 2009,Jul 02 2008,Jul 02 2008,RNA,2,Primary lung tumor,Homo sapiens,Annotation: AD079,Position in Figure 1 (L to R): 109,Age: 67,Sex: M,Histology: AD,Smoking (BI): 900,pTNM: T3N0M0,pStage: IIB,Status: Dead,Survival (days): 1201,Evidence of relapse: Y,Site of relapse: Bone,EGFR status: Wt,K-ras Status: Wt,p53 Status: Mut,Gefitinib treatment:,Position in Figure 2 (L to R): 21,Expression profile-based classification: Non-TRU,Invasion: Definite,Necrosis: Positive,Grade: Poorly,BAC features: -,total RNA,"Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 250 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.",Cy5,"cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescent Linear Amplification kit (Agilent Technologies, Palo Alto, CA).",9606,"Total RNA from 20 lung cell lines representing all major histological types of lung cancers, labeled with Cyanine-3 (green).",Homo sapiens,n/a,total RNA,"Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 250 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.",Cy3,"cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescent Linear Amplification kit (Agilent Technologies, Palo Alto, CA).",9606,"Cy5-sample cRNA and Cy3-common reference cRNA were hybridized to a custom Agilent oligonucleotide microarray, containing a total of 21,619 spots corresponding to 18,175 unique genes, followed by confocal laser scanning (Agilent Technologies).",Scanned on an Agilent G2565AA scanner.,Images were quantified using Agilent Feature Extraction Software (version A.7.5).,n/a,"LOWESS normalized, background subtracted VALUE data obtained from log10 of processed Red signal/processed Green signal. Agilent software was used.",GPL7015,"Takashi,,Takahashi",Aichi Cancer Center,"1-1 Kanokoden, Chikusa-ku",Nagoya,Aichi,464-8681,Japan,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM303nnn/GSM303074/suppl/GSM303074.txt.gz,21619,67,AD079,-,Wt,Y,Non-TRU,,Poorly,AD,Definite,Wt,Positive,Mut,109,21,IIB,T3N0M0,M,Bone,900,Dead,1201
GSM303075,Patient 080 with adenocarcinoma,GSM303075,Public on Apr 01 2009,Jul 02 2008,Jul 02 2008,RNA,2,Primary lung tumor,Homo sapiens,Annotation: AD080,Position in Figure 1 (L to R): 80,Age: 67,Sex: F,Histology: AD,Smoking (BI): 0,pTNM: T2N0M0,pStage: IB,Status: Alive,Survival (days): 1956,Evidence of relapse: N,Site of relapse:,EGFR status: Mut,K-ras Status: Wt,p53 Status: Mut,Gefitinib treatment:,Position in Figure 2 (L to R): 47,Expression profile-based classification: TRU-a,Invasion: Definite but focal,Necrosis: Negative,Grade: Moderately,BAC features: -,total RNA,"Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 250 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.",Cy5,"cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescent Linear Amplification kit (Agilent Technologies, Palo Alto, CA).",9606,"Total RNA from 20 lung cell lines representing all major histological types of lung cancers, labeled with Cyanine-3 (green).",Homo sapiens,n/a,total RNA,"Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 250 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.",Cy3,"cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescent Linear Amplification kit (Agilent Technologies, Palo Alto, CA).",9606,"Cy5-sample cRNA and Cy3-common reference cRNA were hybridized to a custom Agilent oligonucleotide microarray, containing a total of 21,619 spots corresponding to 18,175 unique genes, followed by confocal laser scanning (Agilent Technologies).",Scanned on an Agilent G2565AA scanner.,Images were quantified using Agilent Feature Extraction Software (version A.7.5).,n/a,"LOWESS normalized, background subtracted VALUE data obtained from log10 of processed Red signal/processed Green signal. Agilent software was used.",GPL7015,"Takashi,,Takahashi",Aichi Cancer Center,"1-1 Kanokoden, Chikusa-ku",Nagoya,Aichi,464-8681,Japan,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM303nnn/GSM303075/suppl/GSM303075.txt.gz,21619,67,AD080,-,Mut,N,TRU-a,,Moderately,AD,Definite but focal,Wt,Negative,Mut,80,47,IB,T2N0M0,F,,0,Alive,1956
GSM303076,Patient 081 with adenocarcinoma,GSM303076,Public on Apr 01 2009,Jul 02 2008,Jul 02 2008,RNA,2,Primary lung tumor,Homo sapiens,Annotation: AD081,Position in Figure 1 (L to R): 147,Age: 60,Sex: F,Histology: AD,Smoking (BI): 180,pTNM: T2N2M0,pStage: IIIA,Status: Dead,Survival (days): 749,Evidence of relapse: Y,Site of relapse: PM,EGFR status: Mut,K-ras Status: Wt,p53 Status: Wt,Gefitinib treatment:,Position in Figure 2 (L to R): 33,Expression profile-based classification: Non-TRU,Invasion: Definite,Necrosis: Positive,Grade: Poorly,BAC features: -,total RNA,"Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 250 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.",Cy5,"cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescent Linear Amplification kit (Agilent Technologies, Palo Alto, CA).",9606,"Total RNA from 20 lung cell lines representing all major histological types of lung cancers, labeled with Cyanine-3 (green).",Homo sapiens,n/a,total RNA,"Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 250 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.",Cy3,"cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescent Linear Amplification kit (Agilent Technologies, Palo Alto, CA).",9606,"Cy5-sample cRNA and Cy3-common reference cRNA were hybridized to a custom Agilent oligonucleotide microarray, containing a total of 21,619 spots corresponding to 18,175 unique genes, followed by confocal laser scanning (Agilent Technologies).",Scanned on an Agilent G2565AA scanner.,Images were quantified using Agilent Feature Extraction Software (version A.7.5).,n/a,"LOWESS normalized, background subtracted VALUE data obtained from log10 of processed Red signal/processed Green signal. Agilent software was used.",GPL7015,"Takashi,,Takahashi",Aichi Cancer Center,"1-1 Kanokoden, Chikusa-ku",Nagoya,Aichi,464-8681,Japan,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM303nnn/GSM303076/suppl/GSM303076.txt.gz,21619,60,AD081,-,Mut,Y,Non-TRU,,Poorly,AD,Definite,Wt,Positive,Wt,147,33,IIIA,T2N2M0,F,PM,180,Dead,749
GSM303077,Patient 082 with adenocarcinoma,GSM303077,Public on Apr 01 2009,Jul 02 2008,Jul 02 2008,RNA,2,Primary lung tumor,Homo sapiens,Annotation: AD082,Position in Figure 1 (L to R): 107,Age: 66,Sex: M,Histology: AD,Smoking (BI): 800,pTNM: T1N0M0,pStage: IA,Status: Alive,Survival (days): 2335,Evidence of relapse: N,Site of relapse:,EGFR status: Wt,K-ras Status: Wt,p53 Status: Wt,Gefitinib treatment:,Position in Figure 2 (L to R): 23,Expression profile-based classification: Non-TRU,Invasion: Definite,Necrosis: Negative,Grade: Moderately,BAC features: -,total RNA,"Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 250 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.",Cy5,"cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescent Linear Amplification kit (Agilent Technologies, Palo Alto, CA).",9606,"Total RNA from 20 lung cell lines representing all major histological types of lung cancers, labeled with Cyanine-3 (green).",Homo sapiens,n/a,total RNA,"Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 250 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.",Cy3,"cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescent Linear Amplification kit (Agilent Technologies, Palo Alto, CA).",9606,"Cy5-sample cRNA and Cy3-common reference cRNA were hybridized to a custom Agilent oligonucleotide microarray, containing a total of 21,619 spots corresponding to 18,175 unique genes, followed by confocal laser scanning (Agilent Technologies).",Scanned on an Agilent G2565AA scanner.,Images were quantified using Agilent Feature Extraction Software (version A.7.5).,n/a,"LOWESS normalized, background subtracted VALUE data obtained from log10 of processed Red signal/processed Green signal. Agilent software was used.",GPL7015,"Takashi,,Takahashi",Aichi Cancer Center,"1-1 Kanokoden, Chikusa-ku",Nagoya,Aichi,464-8681,Japan,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM303nnn/GSM303077/suppl/GSM303077.txt.gz,21619,66,AD082,-,Wt,N,Non-TRU,,Moderately,AD,Definite,Wt,Negative,Wt,107,23,IA,T1N0M0,M,,800,Alive,2335
GSM303078,Patient 083 with adenocarcinoma,GSM303078,Public on Apr 01 2009,Jul 02 2008,Jul 02 2008,RNA,2,Primary lung tumor,Homo sapiens,Annotation: AD083,Position in Figure 1 (L to R): 134,Age: 73,Sex: M,Histology: AD,Smoking (BI): 900,pTNM: T1N1M0,pStage: IIA,Status: Dead,Survival (days): 860,Evidence of relapse: Y,Site of relapse: Brain,EGFR status: Mut,K-ras Status: Wt,p53 Status: Wt,Gefitinib treatment:,Position in Figure 2 (L to R): 86,Expression profile-based classification: TRU-b,Invasion: Definite but focal,Necrosis: Focal,Grade: Moderately,BAC features: -,total RNA,"Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 250 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.",Cy5,"cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescent Linear Amplification kit (Agilent Technologies, Palo Alto, CA).",9606,"Total RNA from 20 lung cell lines representing all major histological types of lung cancers, labeled with Cyanine-3 (green).",Homo sapiens,n/a,total RNA,"Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 250 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.",Cy3,"cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescent Linear Amplification kit (Agilent Technologies, Palo Alto, CA).",9606,"Cy5-sample cRNA and Cy3-common reference cRNA were hybridized to a custom Agilent oligonucleotide microarray, containing a total of 21,619 spots corresponding to 18,175 unique genes, followed by confocal laser scanning (Agilent Technologies).",Scanned on an Agilent G2565AA scanner.,Images were quantified using Agilent Feature Extraction Software (version A.7.5).,n/a,"LOWESS normalized, background subtracted VALUE data obtained from log10 of processed Red signal/processed Green signal. Agilent software was used.",GPL7015,"Takashi,,Takahashi",Aichi Cancer Center,"1-1 Kanokoden, Chikusa-ku",Nagoya,Aichi,464-8681,Japan,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM303nnn/GSM303078/suppl/GSM303078.txt.gz,21619,73,AD083,-,Mut,Y,TRU-b,,Moderately,AD,Definite but focal,Wt,Focal,Wt,134,86,IIA,T1N1M0,M,Brain,900,Dead,860
GSM303079,Patient 084 with adenocarcinoma,GSM303079,Public on Apr 01 2009,Jul 02 2008,Jul 02 2008,RNA,2,Primary lung tumor,Homo sapiens,Annotation: AD084,Position in Figure 1 (L to R): 49,Age: 74,Sex: M,Histology: AD,Smoking (BI): 1160,pTNM: T2N0M0,pStage: IB,Status: Dead,Survival (days): 186,Evidence of relapse: Y,Site of relapse: PM,EGFR status: Wt,K-ras Status: Mut,p53 Status: Wt,Gefitinib treatment:,Position in Figure 2 (L to R): 8,Expression profile-based classification: Non-TRU,Invasion: Definite,Necrosis: Positive,Grade: Poorly,BAC features: -,total RNA,"Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 250 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.",Cy5,"cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescent Linear Amplification kit (Agilent Technologies, Palo Alto, CA).",9606,"Total RNA from 20 lung cell lines representing all major histological types of lung cancers, labeled with Cyanine-3 (green).",Homo sapiens,n/a,total RNA,"Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 250 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.",Cy3,"cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescent Linear Amplification kit (Agilent Technologies, Palo Alto, CA).",9606,"Cy5-sample cRNA and Cy3-common reference cRNA were hybridized to a custom Agilent oligonucleotide microarray, containing a total of 21,619 spots corresponding to 18,175 unique genes, followed by confocal laser scanning (Agilent Technologies).",Scanned on an Agilent G2565AA scanner.,Images were quantified using Agilent Feature Extraction Software (version A.7.5).,n/a,"LOWESS normalized, background subtracted VALUE data obtained from log10 of processed Red signal/processed Green signal. Agilent software was used.",GPL7015,"Takashi,,Takahashi",Aichi Cancer Center,"1-1 Kanokoden, Chikusa-ku",Nagoya,Aichi,464-8681,Japan,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM303nnn/GSM303079/suppl/GSM303079.txt.gz,21619,74,AD084,-,Wt,Y,Non-TRU,,Poorly,AD,Definite,Mut,Positive,Wt,49,8,IB,T2N0M0,M,PM,1160,Dead,186
GSM303080,Patient 085 with adenocarcinoma,GSM303080,Public on Apr 01 2009,Jul 02 2008,Jul 02 2008,RNA,2,Primary lung tumor,Homo sapiens,Annotation: AD085,Position in Figure 1 (L to R): 46,Age: 56,Sex: M,Histology: AD,Smoking (BI): 720,pTNM: T3N0M0,pStage: IIB,Status: Alive,Survival (days): 2342,Evidence of relapse: N,Site of relapse:,EGFR status: Wt,K-ras Status: Wt,p53 Status: Wt,Gefitinib treatment:,Position in Figure 2 (L to R): 17,Expression profile-based classification: Non-TRU,Invasion: Definite,Necrosis: Positive,Grade: Poorly,BAC features: -,total RNA,"Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 250 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.",Cy5,"cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescent Linear Amplification kit (Agilent Technologies, Palo Alto, CA).",9606,"Total RNA from 20 lung cell lines representing all major histological types of lung cancers, labeled with Cyanine-3 (green).",Homo sapiens,n/a,total RNA,"Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 250 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.",Cy3,"cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescent Linear Amplification kit (Agilent Technologies, Palo Alto, CA).",9606,"Cy5-sample cRNA and Cy3-common reference cRNA were hybridized to a custom Agilent oligonucleotide microarray, containing a total of 21,619 spots corresponding to 18,175 unique genes, followed by confocal laser scanning (Agilent Technologies).",Scanned on an Agilent G2565AA scanner.,Images were quantified using Agilent Feature Extraction Software (version A.7.5).,n/a,"LOWESS normalized, background subtracted VALUE data obtained from log10 of processed Red signal/processed Green signal. Agilent software was used.",GPL7015,"Takashi,,Takahashi",Aichi Cancer Center,"1-1 Kanokoden, Chikusa-ku",Nagoya,Aichi,464-8681,Japan,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM303nnn/GSM303080/suppl/GSM303080.txt.gz,21619,56,AD085,-,Wt,N,Non-TRU,,Poorly,AD,Definite,Wt,Positive,Wt,46,17,IIB,T3N0M0,M,,720,Alive,2342
GSM303081,Patient 086 with adenocarcinoma,GSM303081,Public on Apr 01 2009,Jul 02 2008,Jul 02 2008,RNA,2,Primary lung tumor,Homo sapiens,Annotation: AD086,Position in Figure 1 (L to R): 79,Age: 49,Sex: F,Histology: AD,Smoking (BI): 0,pTNM: T1N2M0,pStage: IIIA,Status: Dead,Survival (days): 1074,Evidence of relapse: Y,Site of relapse: Brain,EGFR status: Mut,K-ras Status: Wt,p53 Status: Wt,Gefitinib treatment:,Position in Figure 2 (L to R): 50,Expression profile-based classification: TRU-a,Invasion: Definite,Necrosis: Negative,Grade: Moderately,BAC features: -,total RNA,"Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 250 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.",Cy5,"cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescent Linear Amplification kit (Agilent Technologies, Palo Alto, CA).",9606,"Total RNA from 20 lung cell lines representing all major histological types of lung cancers, labeled with Cyanine-3 (green).",Homo sapiens,n/a,total RNA,"Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 250 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.",Cy3,"cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescent Linear Amplification kit (Agilent Technologies, Palo Alto, CA).",9606,"Cy5-sample cRNA and Cy3-common reference cRNA were hybridized to a custom Agilent oligonucleotide microarray, containing a total of 21,619 spots corresponding to 18,175 unique genes, followed by confocal laser scanning (Agilent Technologies).",Scanned on an Agilent G2565AA scanner.,Images were quantified using Agilent Feature Extraction Software (version A.7.5).,n/a,"LOWESS normalized, background subtracted VALUE data obtained from log10 of processed Red signal/processed Green signal. Agilent software was used.",GPL7015,"Takashi,,Takahashi",Aichi Cancer Center,"1-1 Kanokoden, Chikusa-ku",Nagoya,Aichi,464-8681,Japan,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM303nnn/GSM303081/suppl/GSM303081.txt.gz,21619,49,AD086,-,Mut,Y,TRU-a,,Moderately,AD,Definite,Wt,Negative,Wt,79,50,IIIA,T1N2M0,F,Brain,0,Dead,1074
GSM303082,Patient 087 with adenocarcinoma,GSM303082,Public on Apr 01 2009,Jul 02 2008,Jul 02 2008,RNA,2,Primary lung tumor,Homo sapiens,Annotation: AD087,Position in Figure 1 (L to R): 44,Age: 60,Sex: F,Histology: AD,Smoking (BI): 0,pTNM: T2N1M0,pStage: IIB,Status: Dead,Survival (days): 867,Evidence of relapse: Y,"Site of relapse: PM, Liver",EGFR status: Wt,K-ras Status: Wt,p53 Status: Mut,Gefitinib treatment:,Position in Figure 2 (L to R): 35,Expression profile-based classification: Non-TRU,Invasion: Definite,Necrosis: Positive,Grade: Moderately,BAC features: -,total RNA,"Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 250 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.",Cy5,"cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescent Linear Amplification kit (Agilent Technologies, Palo Alto, CA).",9606,"Total RNA from 20 lung cell lines representing all major histological types of lung cancers, labeled with Cyanine-3 (green).",Homo sapiens,n/a,total RNA,"Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 250 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.",Cy3,"cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescent Linear Amplification kit (Agilent Technologies, Palo Alto, CA).",9606,"Cy5-sample cRNA and Cy3-common reference cRNA were hybridized to a custom Agilent oligonucleotide microarray, containing a total of 21,619 spots corresponding to 18,175 unique genes, followed by confocal laser scanning (Agilent Technologies).",Scanned on an Agilent G2565AA scanner.,Images were quantified using Agilent Feature Extraction Software (version A.7.5).,n/a,"LOWESS normalized, background subtracted VALUE data obtained from log10 of processed Red signal/processed Green signal. Agilent software was used.",GPL7015,"Takashi,,Takahashi",Aichi Cancer Center,"1-1 Kanokoden, Chikusa-ku",Nagoya,Aichi,464-8681,Japan,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM303nnn/GSM303082/suppl/GSM303082.txt.gz,21619,60,AD087,-,Wt,Y,Non-TRU,,Moderately,AD,Definite,Wt,Positive,Mut,44,35,IIB,T2N1M0,F,"PM, Liver",0,Dead,867
GSM303083,Patient 088 with adenocarcinoma,GSM303083,Public on Apr 01 2009,Jul 02 2008,Jul 02 2008,RNA,2,Primary lung tumor,Homo sapiens,Annotation: AD088,Position in Figure 1 (L to R): 41,Age: 53,Sex: M,Histology: AD,Smoking (BI): 1320,pTNM: T2N2M0,pStage: IIIA,Status: Dead,Survival (days): 304,Evidence of relapse: Y,Site of relapse: LN (neck),EGFR status: Wt,K-ras Status: Wt,p53 Status: Mut,Gefitinib treatment:,Position in Figure 2 (L to R): 16,Expression profile-based classification: Non-TRU,Invasion: Definite,Necrosis: Positive,Grade: Poorly,BAC features: -,total RNA,"Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 250 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.",Cy5,"cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescent Linear Amplification kit (Agilent Technologies, Palo Alto, CA).",9606,"Total RNA from 20 lung cell lines representing all major histological types of lung cancers, labeled with Cyanine-3 (green).",Homo sapiens,n/a,total RNA,"Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 250 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.",Cy3,"cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescent Linear Amplification kit (Agilent Technologies, Palo Alto, CA).",9606,"Cy5-sample cRNA and Cy3-common reference cRNA were hybridized to a custom Agilent oligonucleotide microarray, containing a total of 21,619 spots corresponding to 18,175 unique genes, followed by confocal laser scanning (Agilent Technologies).",Scanned on an Agilent G2565AA scanner.,Images were quantified using Agilent Feature Extraction Software (version A.7.5).,n/a,"LOWESS normalized, background subtracted VALUE data obtained from log10 of processed Red signal/processed Green signal. Agilent software was used.",GPL7015,"Takashi,,Takahashi",Aichi Cancer Center,"1-1 Kanokoden, Chikusa-ku",Nagoya,Aichi,464-8681,Japan,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM303nnn/GSM303083/suppl/GSM303083.txt.gz,21619,53,AD088,-,Wt,Y,Non-TRU,,Poorly,AD,Definite,Wt,Positive,Mut,41,16,IIIA,T2N2M0,M,LN (neck),1320,Dead,304
GSM303084,Patient 089 with adenocarcinoma,GSM303084,Public on Apr 01 2009,Jul 02 2008,Jul 02 2008,RNA,2,Primary lung tumor,Homo sapiens,Annotation: AD089,Position in Figure 1 (L to R): 5,Age: 51,Sex: M,Histology: AD,Smoking (BI): 56,pTNM: T1N0M0,pStage: IA,Status: Dead,Survival (days): 906,Evidence of relapse: Y,Site of relapse: Brain,EGFR status: Wt,K-ras Status: Wt,p53 Status: Wt,Gefitinib treatment:,Position in Figure 2 (L to R): 15,Expression profile-based classification: Non-TRU,Invasion: Definite,Necrosis: Negative,Grade: Poorly,BAC features: -,total RNA,"Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 250 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.",Cy5,"cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescent Linear Amplification kit (Agilent Technologies, Palo Alto, CA).",9606,"Total RNA from 20 lung cell lines representing all major histological types of lung cancers, labeled with Cyanine-3 (green).",Homo sapiens,n/a,total RNA,"Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 250 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.",Cy3,"cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescent Linear Amplification kit (Agilent Technologies, Palo Alto, CA).",9606,"Cy5-sample cRNA and Cy3-common reference cRNA were hybridized to a custom Agilent oligonucleotide microarray, containing a total of 21,619 spots corresponding to 18,175 unique genes, followed by confocal laser scanning (Agilent Technologies).",Scanned on an Agilent G2565AA scanner.,Images were quantified using Agilent Feature Extraction Software (version A.7.5).,n/a,"LOWESS normalized, background subtracted VALUE data obtained from log10 of processed Red signal/processed Green signal. Agilent software was used.",GPL7015,"Takashi,,Takahashi",Aichi Cancer Center,"1-1 Kanokoden, Chikusa-ku",Nagoya,Aichi,464-8681,Japan,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM303nnn/GSM303084/suppl/GSM303084.txt.gz,21619,51,AD089,-,Wt,Y,Non-TRU,,Poorly,AD,Definite,Wt,Negative,Wt,5,15,IA,T1N0M0,M,Brain,56,Dead,906
GSM303085,Patient 090 with adenocarcinoma,GSM303085,Public on Apr 01 2009,Jul 02 2008,Jul 02 2008,RNA,2,Primary lung tumor,Homo sapiens,Annotation: AD090,Position in Figure 1 (L to R): 110,Age: 74,Sex: M,Histology: AD,Smoking (BI): 800,pTNM: T1N0M0,pStage: IA,Status: Dead,Survival (days): 477,Evidence of relapse: Y,Site of relapse: Local rec.,EGFR status: Wt,K-ras Status: Wt,p53 Status: Wt,Gefitinib treatment:,Position in Figure 2 (L to R): 9,Expression profile-based classification: Non-TRU,Invasion: Definite,Necrosis: Negative,Grade: Poorly,BAC features: -,total RNA,"Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 250 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.",Cy5,"cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescent Linear Amplification kit (Agilent Technologies, Palo Alto, CA).",9606,"Total RNA from 20 lung cell lines representing all major histological types of lung cancers, labeled with Cyanine-3 (green).",Homo sapiens,n/a,total RNA,"Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 250 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.",Cy3,"cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescent Linear Amplification kit (Agilent Technologies, Palo Alto, CA).",9606,"Cy5-sample cRNA and Cy3-common reference cRNA were hybridized to a custom Agilent oligonucleotide microarray, containing a total of 21,619 spots corresponding to 18,175 unique genes, followed by confocal laser scanning (Agilent Technologies).",Scanned on an Agilent G2565AA scanner.,Images were quantified using Agilent Feature Extraction Software (version A.7.5).,n/a,"LOWESS normalized, background subtracted VALUE data obtained from log10 of processed Red signal/processed Green signal. Agilent software was used.",GPL7015,"Takashi,,Takahashi",Aichi Cancer Center,"1-1 Kanokoden, Chikusa-ku",Nagoya,Aichi,464-8681,Japan,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM303nnn/GSM303085/suppl/GSM303085.txt.gz,21619,74,AD090,-,Wt,Y,Non-TRU,,Poorly,AD,Definite,Wt,Negative,Wt,110,9,IA,T1N0M0,M,Local rec.,800,Dead,477
GSM303086,Patient 001 with adenocarcinoma AS001,GSM303086,Public on Apr 01 2009,Jul 02 2008,Jul 02 2008,RNA,2,Primary lung tumor,Homo sapiens,Annotation: AS001,Position in Figure 1 (L to R): 130,Age: 71,Sex: M,Histology: AS,Smoking (BI): 600,pTNM: T2N2M0,pStage: IIIA,Status: Dead,Survival (days): 1425,Evidence of relapse: Y,Site of relapse: Bone,EGFR status: Wt,K-ras Status: Wt,p53 Status: Wt,Gefitinib treatment:,Position in Figure 2 (L to R):,Expression profile-based classification:,Invasion:,Necrosis:,Grade:,BAC features:,total RNA,"Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 250 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.",Cy5,"cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescent Linear Amplification kit (Agilent Technologies, Palo Alto, CA).",9606,"Total RNA from 20 lung cell lines representing all major histological types of lung cancers, labeled with Cyanine-3 (green).",Homo sapiens,n/a,total RNA,"Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 250 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.",Cy3,"cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescent Linear Amplification kit (Agilent Technologies, Palo Alto, CA).",9606,"Cy5-sample cRNA and Cy3-common reference cRNA were hybridized to a custom Agilent oligonucleotide microarray, containing a total of 21,619 spots corresponding to 18,175 unique genes, followed by confocal laser scanning (Agilent Technologies).",Scanned on an Agilent G2565AA scanner.,Images were quantified using Agilent Feature Extraction Software (version A.7.5).,n/a,"LOWESS normalized, background subtracted VALUE data obtained from log10 of processed Red signal/processed Green signal. Agilent software was used.",GPL7015,"Takashi,,Takahashi",Aichi Cancer Center,"1-1 Kanokoden, Chikusa-ku",Nagoya,Aichi,464-8681,Japan,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM303nnn/GSM303086/suppl/GSM303086.txt.gz,21619,71,AS001,,Wt,Y,,,,AS,,Wt,,Wt,130,,IIIA,T2N2M0,M,Bone,600,Dead,1425
GSM303087,Patient 002 with adenocarcinoma AS002,GSM303087,Public on Apr 01 2009,Jul 02 2008,Jul 02 2008,RNA,2,Primary lung tumor,Homo sapiens,Annotation: AS002,Position in Figure 1 (L to R): 11,Age: 71,Sex: M,Histology: AS,Smoking (BI): 700,pTNM: T3N1M0,pStage: IIIA,Status: Dead,Survival (days): 309,Evidence of relapse: Y,Site of relapse: Skin,EGFR status: Wt,K-ras Status: Wt,p53 Status: Mut,Gefitinib treatment:,Position in Figure 2 (L to R):,Expression profile-based classification:,Invasion:,Necrosis:,Grade:,BAC features:,total RNA,"Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 250 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.",Cy5,"cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescent Linear Amplification kit (Agilent Technologies, Palo Alto, CA).",9606,"Total RNA from 20 lung cell lines representing all major histological types of lung cancers, labeled with Cyanine-3 (green).",Homo sapiens,n/a,total RNA,"Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 250 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.",Cy3,"cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescent Linear Amplification kit (Agilent Technologies, Palo Alto, CA).",9606,"Cy5-sample cRNA and Cy3-common reference cRNA were hybridized to a custom Agilent oligonucleotide microarray, containing a total of 21,619 spots corresponding to 18,175 unique genes, followed by confocal laser scanning (Agilent Technologies).",Scanned on an Agilent G2565AA scanner.,Images were quantified using Agilent Feature Extraction Software (version A.7.5).,n/a,"LOWESS normalized, background subtracted VALUE data obtained from log10 of processed Red signal/processed Green signal. Agilent software was used.",GPL7015,"Takashi,,Takahashi",Aichi Cancer Center,"1-1 Kanokoden, Chikusa-ku",Nagoya,Aichi,464-8681,Japan,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM303nnn/GSM303087/suppl/GSM303087.txt.gz,21619,71,AS002,,Wt,Y,,,,AS,,Wt,,Mut,11,,IIIA,T3N1M0,M,Skin,700,Dead,309
GSM303088,Patient 003 with adenocarcinoma AS003,GSM303088,Public on Apr 01 2009,Jul 02 2008,Jul 02 2008,RNA,2,Primary lung tumor,Homo sapiens,Annotation: AS003,Position in Figure 1 (L to R): 141,Age: 52,Sex: M,Histology: AS,Smoking (BI): 440,pTNM: T1N0M0,pStage: IA,Status: Dead,Survival (days): 2428,Evidence of relapse: Y,Site of relapse: Brain,EGFR status: Mut,K-ras Status: Wt,p53 Status: Mut,Gefitinib treatment: Y,Position in Figure 2 (L to R):,Expression profile-based classification:,Invasion:,Necrosis:,Grade:,BAC features:,total RNA,"Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 250 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.",Cy5,"cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescent Linear Amplification kit (Agilent Technologies, Palo Alto, CA).",9606,"Total RNA from 20 lung cell lines representing all major histological types of lung cancers, labeled with Cyanine-3 (green).",Homo sapiens,n/a,total RNA,"Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 250 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.",Cy3,"cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescent Linear Amplification kit (Agilent Technologies, Palo Alto, CA).",9606,"Cy5-sample cRNA and Cy3-common reference cRNA were hybridized to a custom Agilent oligonucleotide microarray, containing a total of 21,619 spots corresponding to 18,175 unique genes, followed by confocal laser scanning (Agilent Technologies).",Scanned on an Agilent G2565AA scanner.,Images were quantified using Agilent Feature Extraction Software (version A.7.5).,n/a,"LOWESS normalized, background subtracted VALUE data obtained from log10 of processed Red signal/processed Green signal. Agilent software was used.",GPL7015,"Takashi,,Takahashi",Aichi Cancer Center,"1-1 Kanokoden, Chikusa-ku",Nagoya,Aichi,464-8681,Japan,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM303nnn/GSM303088/suppl/GSM303088.txt.gz,21619,52,AS003,,Mut,Y,,Y,,AS,,Wt,,Mut,141,,IA,T1N0M0,M,Brain,440,Dead,2428
GSM303089,Patient 004 with adenocarcinoma AS004,GSM303089,Public on Apr 01 2009,Jul 02 2008,Jul 02 2008,RNA,2,Primary lung tumor,Homo sapiens,Annotation: AS004,Position in Figure 1 (L to R): 101,Age: 73,Sex: M,Histology: AS,Smoking (BI): 1200,pTNM: T1N0M0,pStage: IA,Status: Alive,Survival (days): 3066,Evidence of relapse: N,Site of relapse:,EGFR status: Wt,K-ras Status: Wt,p53 Status: Mut,Gefitinib treatment:,Position in Figure 2 (L to R):,Expression profile-based classification:,Invasion:,Necrosis:,Grade:,BAC features:,total RNA,"Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 250 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.",Cy5,"cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescent Linear Amplification kit (Agilent Technologies, Palo Alto, CA).",9606,"Total RNA from 20 lung cell lines representing all major histological types of lung cancers, labeled with Cyanine-3 (green).",Homo sapiens,n/a,total RNA,"Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 250 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.",Cy3,"cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescent Linear Amplification kit (Agilent Technologies, Palo Alto, CA).",9606,"Cy5-sample cRNA and Cy3-common reference cRNA were hybridized to a custom Agilent oligonucleotide microarray, containing a total of 21,619 spots corresponding to 18,175 unique genes, followed by confocal laser scanning (Agilent Technologies).",Scanned on an Agilent G2565AA scanner.,Images were quantified using Agilent Feature Extraction Software (version A.7.5).,n/a,"LOWESS normalized, background subtracted VALUE data obtained from log10 of processed Red signal/processed Green signal. Agilent software was used.",GPL7015,"Takashi,,Takahashi",Aichi Cancer Center,"1-1 Kanokoden, Chikusa-ku",Nagoya,Aichi,464-8681,Japan,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM303nnn/GSM303089/suppl/GSM303089.txt.gz,21619,73,AS004,,Wt,N,,,,AS,,Wt,,Mut,101,,IA,T1N0M0,M,,1200,Alive,3066
